Section 12

EurekaMag PDF full texts Chapter 11,036


Du, J.; Zhou, S.; Coggeshall, R.E.; Carlton, S.M. 2003: N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 118(2): 547-562
Sun, Q.; Ooi, V.E.; Chan, S.O. 2001: N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801. Experimental Brain Research 138(1): 37-45
van Dam, E.J.M.; Ruiter, B.; Kamal, A.; Ramakers, G.M.J.; Gispen, W.Hendrik.; de Graan, P.N.E. 2002: N-methyl-D-aspartate-induced long-term depression is associated with a decrease in postsynaptic protein kinase C substrate phosphorylation in rat hippocampal slices. Neuroscience Letters 320(3): 129-132
Prime, L.; Pichon, Y.; Moore, L.E. 1999: N-Methyl-D-aspartate-induced oscillations in whole cell clamped neurons from the isolated spinal cord of Xenopus laevis embryos. Journal of Neurophysiology 82(2): 1069-1073
Johnson, S.M.; Mitchell, G.S. 1998: N-methyl-D-aspartate-mediated bulbospinal respiratory drive is pH/P(CO2)-insensitive in turtle brainstem-spinal cord. Respiration Physiology 113(3): 201-212
Borsello, T.; Croquelois, K.; Hornung, J-Pierre.; Clarke, P.G.H. 2003: N-methyl-D-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. European Journal of Neuroscience 18(3): 473-485
Aicher, S.A.; Hahn, B.; Milner, T.A. 2000: N-methyl-D-aspartate-type glutamate receptors are found in post-synaptic targets of adrenergic terminals in the thoracic spinal cord. Brain Research 856(1-2): 1-11
Dracheva, S.; Marras, S.A.; Elhakem, S.L.; Kramer, F.R.; Davis, K.L.; Haroutunian, V. 2001: N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. American Journal of Psychiatry 158(9): 1400-1410
Stanojlović, O.; Zivanović, D.; Susić, V. 2000: N-Methyl-D-aspartic acid- and metaphit-induced audiogenic seizures in rat model of seizures. Pharmacological Research 42(3): 247-253
Tarui, A.; Shibata, K.; Takahashi, S.; Kera, Y.; Munegumi, T.; Yamada, R-Hei. 2003: N-methyl-D-glutamate and N-methyl-L-glutamate in Scapharca broughtonii (Mollusca) and other invertebrates. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 134(1): 79-87
Sakai, S.; Sayo, T.; Kodama, S.; Inoue, S. 1999: N-Methyl-L-serine stimulates hyaluronan production in human skin fibroblasts. Skin Pharmacology and Applied Skin Physiology 12(5): 276-283
Thümen, A.; Behnecke, A.; Qadri, F.; Moser, A. 2003: N-methyl-norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioural changes. International Journal of Neuropsychopharmacology 6(1): 35-40
Thümen, A.; Behnecke, A.; Qadri, F.; Bäuml, E.; Thümen, A.; Behnecke, C.A.; Qadri, F.; Bäuml, E.; Moser, A. 2002: N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo. Neuroreport 13(1): 25-28
Andreozzi, R.; Casale, M.-Simona-Lo; Marotta, R.; Pinto, G.; Pollio, A. 2000: N-methyl-p-aminophenol (metol) ozonation in aqueous solution: Kinetics, mechanism and toxicological characterization of ozonized samples. Water Research 34(18): 4419-4429
Park, T.H.; Kwon, O.S.; Park, S.Y.; Han, E.S.; Lee, C.S. 2003: N-methylated beta-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change. Neuroscience Research 46(3): 349-358
Dechantsreiter, M.A.; Planker, E.; Mathä, B.; Lohof, E.; Hölzemann, G.; Jonczyk, A.; Goodman, S.L.; Kessler, H. 1999: N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. Journal of Medicinal Chemistry 42(16): 3033-3040
Aoyama, K.; Matsubara, K.; Okada, K.; Fukushima, S.; Shimizu, K.; Yamaguchi, S.; Uezono, T.; Satomi, M.; Hayase, N.; Ohta, S.; Shiono, H.; Kobayashi, S. 2000: N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: Nicotinamide loading test. Journal of Neural Transmission 107(8-9): 985-995
Kooistra, O.; Lüneberg, E.; Knirel, Y.A.; Frosch, M.; Zähringer, U. 2002: N-Methylation in polylegionaminic acid is associated with the phase-variable epitope of Legionella pneumophila serogroup 1 lipopolysaccharide. Identification of 5-(N,N-dimethylacetimidoyl)amino and 5-acetimidoyl(N-methyl)amino-7-acetamido-3,5,7,9-tetradeoxynon-2-ulosonic acid in the O-chain polysaccharide. European Journal of Biochemistry 269(2): 560-572
Matsubara, K.; Aoyama, K.; Suno, M.; Awaya, T. 2002: N-methylation underlying Parkinson's disease. Neurotoxicology and Teratology 24(5): 593-598
Kakefuda, A.; Tsukada, J.; Kusayama, T.; Tahara, A.; Tsukamoto, S-ichi. 2002: N-Methylbenzanilide derivatives as a novel class of selective V(1A) receptor antagonists. Bioorganic and Medicinal Chemistry Letters 12(2): 229-232
Käfferlein, H.U.; Angerer, J. 2001: N-methylcarbamoylated valine of hemoglobin in humans after exposure to N,N-dimethylformamide: evidence for the formation of methyl isocyanate?. Chemical Research in Toxicology 14(7): 833-840
Ramos, V.M.; Rodriguez, N.M.; Diaz, M.F.; Rodriguez, M.S.; Heras, A.; Agullo, E. 2003: N-methylene phosphonic chitosan. Effect of preparation methods on its properties. Carbohydrate Polymers 52(1): 39-46, 1 April
Rajdev, L.; Yu, Z.F.; Wadler, S.; Weller, E.; Kahn, S.B.; Tormey, D.; Skeel, R.; Wiernik, P.H. 2001: N-methylformamide in advanced squamous cancer of the uterine cervix: An Eastern Cooperative Oncology Group phase II trial. Investigational New Drugs 19(3): 233-237
Shao, X.; Lisi, J.M.; Butch, E.R.; Kilbourn, M.R.; Snyder, S.E. 2003: N-methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity. Nuclear Medicine and Biology 30(3): 293-302
Gamble, J.T.; Dailey, H.A.; Marks, G.S. 2000: N-Methylprotoporphyrin is a more potent inhibitor of recombinant human than of recombinant chicken ferrochelatase. Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(4): 373-375
Vandevoorde, Séverine.; Lambert, D.M.; Smart, D.; Jonsson, K.Olov.; Fowler, C.J. 2003: N-morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. Bioorganic and Medicinal Chemistry 11(6): 817-825
Ferrer, I.; Blanco, R. 2000: N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Research. Molecular Brain Research 77(2): 270-276
Breit, S.; Rössler, J.; Fotsis, T.; Schweigerer, L. 2000: N-myc down-regulates activin a. Biochemical and Biophysical Research Communications 274(2): 405-409
Boon, K.; Caron, H.N.; van Asperen, R.; Valentijn, L.; Hermus, M.C.; van Sluis, P.; Roobeek, I.; Weis, I.; Voûte, P.A.; Schwab, M.; Versteeg, R. 2001: N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO Journal 20(6): 1383-1393
Knoepfler, P.S.; Cheng, P.F.; Eisenman, R.N. 2002: N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes and Development 16(20): 2699-2712
Hatzi, E.; Murphy, C.; Zoephel, A.; Ahorn, H.; Tontsch, U.; Bamberger, A-Maria.; Yamauchi-Takihara, K.; Schweigerer, L.; Fotsis, T. 2002: N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma. European Journal of Biochemistry 269(15): 3732-3741
Wartiovaara, K.; Barnabe-Heider, F.; Miller, F.D.; Kaplan, D.R. 2002: N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(3): 815-824
Chambéry, D.; Mohseni-Zadeh, S.; de Gallé, B.; Babajko, S. 1999: N-myc regulation of type i insulin-like growth factor receptor in a human neuroblastoma cell line. Cancer Research 59(12): 2898-2902
Shimono, A.; Okuda, T.; Kondoh, H. 1999: N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mechanisms of Development 83(1-2): 39-52
Wang, Y.; Windh, R.T.; Chen, C.A.; Manning, D.R. 1999: N-Myristoylation and betagamma play roles beyond anchorage in the palmitoylation of the G protein alpha(o) subunit. Journal of Biological Chemistry 274(52): 37435-37442
Ramdas, L.; Obeyesekere, N.U.; Sun, G.; McMurray, J.S.; Budde, R.J. 1999: N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor. Journal of Peptide Research: Official Journal of the American Peptide Society 53(5): 569-577
Rajala, R.V.; Datla, R.S.; Moyana, T.N.; Kakkar, R.; Carlsen, S.A.; Sharma, R.K. 2000: N-myristoyltransferase. Molecular and Cellular Biochemistry 204(1-2): 135-155
Cervetto, L.; Demontis, G.C.; Giannaccini, G.; Longoni, B.; Macchia, B.; Macchia, M.; Martinelli, A.; Orlandini, E. 1998: N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies. Journal of Medicinal Chemistry 41(25): 4933-4938
Zwickenpflug, W. 2000: N-Nitrosation of myosmine yields HPB (4-hydroxy-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). Journal of Agricultural and Food Chemistry 48(2): 392-394
Atawodi, S.E. 2003: N-nitroso compound precursors in some Nigerian forage crops. Tropical Veterinarian 21(2): 1-8
Guadagni, S.; Pistoia, M.A.; Amicucci, G.; Leocata, P.; Ventura, L.; Ventura, T.; Chiominto, A.; Deraco, M.; Vaglini, M. 1999: N-nitroso compounds and Helicobacter pylori in the gastric remnant. Tumori 85(2): 108-112
Mirvish, S.S.; Haorah, J.; Zhou, L.; Hartman, M.; Morris, C.R.; Clapper, M.L. 2003: N-nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef. Carcinogenesis 24(3): 595-603
Guadagni, S.; Pistoia, M.A.; Valenti, M.; Leocata, P.; Coletti, G.; Calvisi, G.; Madonna, R.; Deraco, M.; Reed, P.I. 1998: N-Nitroso compounds, bacteria, and carcinoembryonic antigen in the gastric stump. Journal of Surgical Research 80(2): 345-351
Brown-Peterson, N.J.; Krol, R.M.; Zhu, Y.; Hawkins, W.E. 1999: N-nitrosodiethylamine initiation of carcinogenesis in Japanese medaka (Oryzias latipes): hepatocellular proliferation, toxicity, and neoplastic lesions resulting from short term, low level exposure. Toxicological Sciences: An Official Journal of the Society of Toxicology 50(2): 186-194
Choi, J.; Valentine, R.L. 2003: N-nitrosodimethylamine formation by free-chlorine-enhanced nitrosation of dimethylamine. Environmental Science and Technology 37(21): 4871-4876
Lin, H.; Hollenberg, P.F. 2001: N-nitrosodimethylamine-mediated formation of oxidized and methylated dna bases in a cytochrome P450 2E1 expressing cell line. Chemical Research in Toxicology 14(5): 562-566
Frei, E.; Kuchenmeister, F.; Gliniorz, R.; Breuer, A.; Schmezer, P. 2001: N-nitrososdimethylamine is activated in microsomes from hepatocytes to reactive metabolites which damage DNA of non-parenchymal cells in rat liver. Toxicology Letters 123(2-3): 227-234
Price, J.D.; Grimley Evans, J. 2002: N-of-1 randomized controlled trials ('N-of-1 trials'): singularly useful in geriatric medicine. Age and Ageing 31(4): 227-232
Chu, C.J.; Huang, S.M.; De Petrocellis, L.; Bisogno, T.; Ewing, S.A.; Miller, J.D.; Zipkin, R.E.; Daddario, N.; Appendino, G.; Di Marzo, V.; Walker, J.M. 2003: N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. Journal of Biological Chemistry 278(16): 13633-13639
Spinedi, A.; Di Bartolomeo, S.; Piacentini, M. 1999: N-Oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: possible implications for apoptosis. Biochemical and Biophysical Research Communications 255(2): 456-459
Abdullah, M.S.; Yee, N.C.; Damani, L. 2002: N-oxidation of dietary-derived trimethylamine in ethnic Malaysian malays, Chinese and Indians. Biomedical Research 13(2-3): 95-98
Cashman, J.R.; Xiong, Y.N.; Xu, L.; Janowsky, A. 1999: N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication. Journal of Pharmacology and Experimental Therapeutics 288(3): 1251-1260
Liao, W.; Piskorz, C.F.; Locke, R.D.; Matta, K.L. 2000: N-p-Nitrobenzyloxycarbonyl galactosamine imidate as a glycosyl donor for the efficient synthesis of mucin core-2 analogue. Bioorganic and Medicinal Chemistry Letters 10(8): 793-795
Sung, N.-Do; Lee, S.-Ho; Ryu, J.-Wook; Woo, J.-Chun; Koo, D.-Whan; Kim, D.-Whang 2000: N-phenyl substitutent effect on the herbicidal activity of 2-(4-(6-chloro-2-benzoxazolyloxy)phenoxy)-N-phenylpropionamide derivatives against rice plant with pre- and post-emergence. Agricultural Chemistry and Biotechnology 43(1): 52-56
Wan, Z.; Boehm, J.C.; Bower, M.J.; Kassis, S.; Lee, J.C.; Zhao, B.; Adams, J.L. 2003: N-Phenyl-N-purin-6-yl ureas: the design and synthesis of p38alpha MAP kinase inhibitors. Bioorganic and Medicinal Chemistry Letters 13(6): 1191-1194
Prakash, K.R.; Tamiz, A.P.; Araldi, G.L.; Zhang, M.; Johnson, K.M.; Kozikowski, A.P. 1999: N-phenylalkyl-substituted tropane analogs of boat conformation with high selectivity for the dopamine versus serotonin transporter. Bioorganic and Medicinal Chemistry Letters 9(23): 3325-3328
Gerner, P.; Mujtaba, M.; Khan, M.; Sudoh, Y.; Vlassakov, K.; Anthony, D.C.; Wang, G.Kuo. 2002: N-phenylethyl amitriptyline in rat sciatic nerve blockade. Anesthesiology 96(6): 1435-1442
Kawai, R.; Sugimoto, J.; Kataoka, M.; Hayakawa, Y. 2001: N-phenylimidazolium triflate as a highly effective promoter for the interribonucleotide-bond formation via the phosphoramidite method. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 1047-1048
Kumar, D.; David, W.M.; Kerwin, S.M. 2001: N-propargyl-2-alkynylbenzothiazolium aza-enediynes: Role of the 2-alkynylbenzothiazolium functionality in DNA cleavage. Bioorganic and Medicinal Chemistry Letters 11(22): 2971-2974
Collin, X.; Robert, J.M.; Robert, S.; Le-Baut, G.; Bobin-Dubigeon, C.; Grimaud, N.; Lang, F.; Petit, J.Y. 1999: N-pyridinyl(alkyl)polyhalogenobenzamides acting as TNF-alpha production inhibitors. Pharmacy and Pharmacology Communications 5(3): 233-238
Tsurumi, S.; Nakamura, Y.; Maki, K.; Omine, M.; Fujita, K.; Okamura, T.; Niho, Y.; Hashimoto, S.; Kanno, K.; Suzuki, K.; Hangaishi, A.; Ogawa, S.; Hirai, H.; Mitani, K. 2002: N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders. American Journal of Hematology 71(2): 131-133
Mayr, B.; Holzheu, M.; Schaffner, G.; Reifinger, M. 2003: N-ras mutation in a canine lymphoma: short communication. Acta Veterinaria Hungarica 51(1): 91-94
Jiveskog, S.; Ragnarsson-Olding, B.; Platz, A.; Ringborg, U. 1998: N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. Journal of Investigative Dermatology 111(5): 757-761
Beun, J.J.; Heijnen, J.J.; van Loosdrecht, M.C. 2001: N-removal in a granular sludge sequencing batch airlift reactor. Biotechnology and Bioengineering 75(1): 82-92
Birch, A.M.; Bradley, P.A.; Gill, J.C.; Kerrigan, F.; Needham, P.L. 1999: N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents. Journal of Medicinal Chemistry 42(17): 3342-3355
Sykes, B.M.; Atwell, G.J.; Hogg, A.; Wilson, W.R.; O'Connor, C.J.; Denny, W.A. 1999: N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization. Journal of Medicinal Chemistry 42(3): 346-355
Lodder, M.; Wang, B.; Hecht, S.M. 2000: N-substituted 2-amino-4-pentenoic acids for amino acid protection and resolution. Tetrahedron 56(48): 9421-9429, 24 November
Baston, E.; Hartmann, R.W. 1999: N-substituted 4-(5-indolyl)benzoic acids. Synthesis and evaluation of steroid 5alpha-reductase type I and II inhibitory activity. Bioorganic and Medicinal Chemistry Letters 9(11): 1601-1606
El Hadri, A.; Abouabdellah, A.; Thomet, U.; Baur, R.; Furtmüller, R.; Sigel, E.; Sieghart, W.; Dodd, R.H. 2002: N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA(A) receptor sharing electrophysiological properties with the anticonvulsant loreclezole. Journal of Medicinal Chemistry 45(13): 2824-2831
Knutsen, L.J.; Lau, J.; Petersen, H.; Thomsen, C.; Weis, J.U.; Shalmi, M.; Judge, M.E.; Hansen, A.J.; Sheardown, M.J. 1999: N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects. Journal of Medicinal Chemistry 42(18): 3463-3477
Lindgren, H.; Pero, R.W.; Ivars, F.; Leanderson, T. 2001: N-substituted benzamides inhibit nuclear factor-kappaB and nuclear factor of activated T cells activity while inducing activator protein 1 activity in T lymphocytes. Molecular Immunology 38(4): 267-277
Uesato, S.; Hashimoto, Y.; Nishino, M.; Nagaoka, Y.; Kuwajima, H. 2002: N-substituted hydroxyureas as urease inhibitors. Chemical and Pharmaceutical Bulletin 50(9): 1280-1282
Ahn, K.H.; Lee, S.J.; Lee, C.H.; Hong, C.Y.; Park, T.K. 1999: N-substituted-3-arylpyrrolidines: Potent and selective ligands at serotonin 1A receptor. Bioorganic and Medicinal Chemistry Letters 9(10): 1379-1384
Salerno, L.; Sorrenti, V.; Guerrera, F.; Sarva, M.C.; Siracusa, M.A.; Di-Giacomo, C.; Vanella, A. 1999: N-substituted-imidazoles as inhibitors of nitric oxide synthase: A preliminary screening. Pharmazie 54(9): 685-690
Bulychev, A.; Bellettini, J.R.; O'brien, M.; Crocker, P.J.; Samama, J.P.; Miller, M.J.; Mobashery, S. 2000: N-sulfonyloxy-beta-lactam inhibitors for beta-lactamases. Tetrahedron 56(31): 5719-5728, 28 July
Shiraga, T.; Hata, T.; Yamazoe, Y.; Ohno, Y.; Iwasaki, K. 1999: N-sulphoconjugation of amines by human cytosolic hydroxysteroid sulphotransferase. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 29(4): 341-347
Kinnunen, A.; Kinnunen, T.; Kaksonen, M.; Nolo, R.; Panula, P.; Rauvala, H. 1998: N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. European Journal of Neuroscience 10(2): 635-648
Atamna, H.; Paler-Martínez, A.; Ames, B.N. 2000: N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. Journal of Biological Chemistry 275(10): 6741-6748
Monné, M.; Gafvelin, G.; Nilsson, R.; von Heijne, G. 1999: N-tail translocation in a eukaryotic polytopic membrane protein: synergy between neighboring transmembrane segments. European Journal of Biochemistry 263(1): 264-269
Bak, A.; Fich, M.; Larsen, B.D.; Frokjaer, S.; Friis, G.J. 1999: N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: Synthesis, chemical and enzymatic stability studies. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 7(4): 317-323
da Silva Tatley, F.; Aldwell, F.E.; Dunbier, A.K.; Guilford, P.J. 2003: N-terminal E-cadherin peptides act as decoy receptors for Listeria monocytogenes. Infection and Immunity 71(3): 1580-1583
Shenolikar, S.; Minkoff, C.M.; Steplock, D.A.; Evangelista, C.; Liu, M.; Weinman, E.J. 2001: N-terminal PDZ domain is required for NHERF dimerization. FEBS Letters 489(2-3): 233-236
Eldstrom, J.; Doerksen, K.W.; Steele, D.F.; Fedida, D. 2002: N-terminal PDZ-binding domain in Kv1 potassium channels. FEBS Letters 531(3): 529-537
Santagata, S.; Gomez, C.A.; Sobacchi, C.; Bozzi, F.; Abinun, M.; Pasic, S.; Cortes, P.; Vezzoni, P.; Villa, A. 2000: N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proceedings of the National Academy of Sciences of the United States of America 97(26): 14572-14577
Piper, M.; Nurcombe, V.; Reid, K.; Bartlett, P.; Little, M. 2002: N-terminal Slit2 promotes survival and neurite extension in cultured peripheral neurons. Neuroreport 13(17): 2375-2378
Mima, J.; Kondo, T.; Hayashi, R. 2002: N-terminal acetyl group is essential for the inhibitory function of carboxypeptidase Y inhibitor (I(C)). FEBS Letters 532(1-2): 207-210
Charbaut, E.; Redeker, V.; Rossier, J.; Sobel, Aé. 2002: N-terminal acetylation of ectopic recombinant proteins in Escherichia coli. FEBS Letters 529(2-3): 341-345
Polevoda, B.; Sherman, F. 2003: N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. Journal of Molecular Biology 325(4): 595-622
Mezaki, Y.; Yoshida, T.; Yanagisawa, J.; Kato, S. 2001: N-terminal activation function is dominant in ligand-dependent transactivation of medaka estrogen receptor alpha in human cells. Biochemical and Biophysical Research Communications 289(3): 763-768
Dasgupta, P.; Singh, A.; Mukherjee, R. 2002: N-terminal acylation of somatostatin analog with long chain fatty acids enhances its stability and anti-proliferative activity in human breast adenocarcinoma cells. Biological and Pharmaceutical Bulletin 25(1): 29-36
Maruyama, M.; Sugiki, M.; Anai, K.; Yoshida, E. 2002: N-terminal amino acid sequences and some characteristics of fibrinolytic/hemorrhagic metalloproteinases purified from Bothrops jararaca venom. Toxicon: Official Journal of the International Society on Toxinology 40(8): 1223-1226
Kramer, G.; Kudlicki, W.; Mccarthy, D.; Tsalkova, T.; Simmons, D.; Hardesty, B. 1999: N-terminal and C-terminal modifications affect folding, release from the ribosomes and stability of in vitro synthesized proteins. International Journal of Biochemistry and Cell Biology 31(1): 231-241
Klapisz, E.; Ziari, M.; Wendum, D.; Koumanov, K.; Brachet-Ducos, C.; Olivier, J.L.; Béréziat, G.; Trugnan, G.; Masliah, J. 1999: N-terminal and C-terminal plasma membrane anchoring modulate differently agonist-induced activation of cytosolic phospholipase A2. European Journal of Biochemistry 265(3): 957-966
Jensen, L.H.; Wessel, I.; Møller, M.; Nitiss, J.L.; Sehested, M.; Jensen, P.B. 2000: N-terminal and core-domain random mutations in human topoisomerase Ii alpha conferring bisdioxopiperazine resistance. Febs Letters 480(2-3): 201-207
Arnlöv, J.; Lind, L.; Stridsberg, M.; Andrén, B.; Lithell, H. 2000: N-terminal atrial natriuretic peptide and left ventricular geometry and function in a population sample of elderly males. Journal of Internal Medicine 247(6): 699-708
Reis, E.M.; Kurtenbach, E.; Ferreira, A.R.; Biselli, P.J.; Slayman, C.W.; Verjovski-Almeida, S. 1999: N-terminal chimeric constructs improve the expression of sarcoplasmic reticulum Ca(2+)-ATPase in yeast. Biochimica et Biophysica Acta 1461(1): 83-95
Brekke, J.F.; Osol, G.J.; Helle, K.B. 2002: N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries. Regulatory Peptides 105(2): 93-100
Fujisawa, R.; McAtee, F.J.; Favara, C.; Hayes, S.F.; Portis, J.L. 2001: N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles. Journal of Virology 75(22): 11239-11243
Gao, G.; Dou, Q.P. 2000: N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. Journal of Cellular Biochemistry 80(1): 53-72
Rickman, L.; Simrak, D.; Stevens, H.P.; Hunt, D.M.; King, I.A.; Bryant, S.P.; Eady, R.A.; Leigh, I.M.; Arnemann, J.; Magee, A.I.; Kelsell, D.P.; Buxton, R.S. 1999: N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Human Molecular Genetics 8(6): 971-976
Doray, B.; Chen, C.D.; Kemper, B. 2001: N-terminal deletions and His-tag fusions dramatically affect expression of cytochrome p450 2C2 in bacteria. Archives of Biochemistry and Biophysics 393(1): 143-153
Höllerer-Beitz, G.; Schönherr, R.; Koenen, M.; Heinemann, S.H. 1999: N-terminal deletions of rKv1.4 channels affect the voltage dependence of channel availability. Pflugers Archiv: European Journal of Physiology 438(2): 141-146
Schnappauf, F.; Hake, S.B.; Camacho Carvajal, M.M.; Bontron, S.év.; Lisowska-Grospierre, B.; Steimle, V. 2003: N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class Ii transactivator CIITA. European Journal of Immunology 33(8): 2337-2347
Luque, I.; Zong, W.X.; Chen, C.; Gelinas, C. 2000: N-terminal determinants of Ikappa Balpha necessary for the cytoplasmic regulation of c-Rel. Oncogene 19(9): 1239-1244
Gillen, K.M.; Pausch, M.; Dohlman, H.G. 1998: N-terminal domain of Gpa1 (G protein alpha) subunit) is sufficient for plasma membrane targeting in yeast Saccharomyces cerevisiae. Journal of Cell Science 111: 3235-3244
Segrest, J.P.; Jones, M.K.; Dashti, N. 1999: N-terminal domain of apolipoprotein B has structural homology to lipovitellin and microsomal triglyceride transfer protein: a "lipid pocket" model for self-assembly of apob-containing lipoprotein particles. Journal of Lipid Research 40(8): 1401-1416
Friedman, K.L.; Heit, J.J.; Long, D.M.; Cech, T.R. 2003: N-terminal domain of yeast telomerase reverse transcriptase: recruitment of Est3p to the telomerase complex. Molecular Biology of the Cell 14(1): 1-13
Crane, B.R.; Rosenfeld, R.J.; Arvai, A.S.; Ghosh, D.K.; Ghosh, S.; Tainer, J.A.; Stuehr, D.J.; Getzoff, E.D. 1999: N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization. EMBO Journal 18(22): 6271-6281
Gongadze, G.M.; Meshcheryakov, V.A.; Serganov, A.A.; Fomenkova, N.P.; Mudrik, E.S.; Jonsson, B.H.; Liljas, A.; Nikonov, S.V.; Garber, M.B. 1999: N-terminal domain, residues 1-91, of ribosomal protein TL5 from Thermus thermophilus binds specifically and strongly to the region of 5S rRNA containing loop E. FEBS Letters 451(1): 51-55
Trask, T.M.; Ritty, T.M.; Broekelmann, T.; Tisdale, C.; Mecham, R.P. 1999: N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly. Biochemical Journal 340: 693-701
Hill, K.M.; Huang, Y.; Yip, S.C.; Yu, J.; Segall, J.E.; Backer, J.M. 2001: N-terminal domains of the class ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling. Journal of Biological Chemistry 276(19): 16374-16378
Armbruster, B.N.; Banik, S.S.; Guo, C.; Smith, A.C.; Counter, C.M. 2001: N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Molecular and Cellular Biology 21(22): 7775-7786
Korepanova, A.; Douglas, C.; Leyngold, I.; Logan, T.M. 2001: N-terminal extension changes the folding mechanism of the FK506-binding protein. Protein Science: a Publication of the Protein Society 10(9): 1905-1910
Haas, A.Louise.; Sabina, R.L. 2003: N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L. Biochemical and Biophysical Research Communications 305(2): 421-427
Kohtz, J.D.; Lee, H.Y.; Gaiano, N.; Segal, J.; Ng, E.; Larson, T.; Baker, D.P.; Garber, E.A.; Williams, K.P.; Fishell, G. 2001: N-terminal fatty-acylation of sonic hedgehog enhances the induction of rodent ventral forebrain neurons. Development 128(12): 2351-2363
Franz, M.; Woloszczuk, W.; Hörl, W.H. 2000: N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Kidney International 58(1): 374-383
Franz, M.; Woloszczuk, W.; Hörl, W.H. 2001: N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients. Transplantation 72(1): 89-94
Abdel-Wahab, Y.H.; O'Harte, F.P.; Mooney, M.H.; Conlon, J.M.; Flatt, P.R. 1999: N-terminal glycation of cholecystokinin-8 abolishes its insulinotropic action on clonal pancreatic B-cells. Biochimica et Biophysica Acta 1452(1): 60-67
Terada, T.; Saito, H.; Sawada, K.; Hashimoto, Y.; Inui, K. 2000: N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition. Pharmaceutical Research 17(1): 15-20
Sakoh, M.; Okazaki, T.; Nagaoka, Y.; Asami, K. 2003: N-terminal insertion of alamethicin in channel formation studied using its covalent dimer N-terminally linked by disulfide bond. Biochimica et Biophysica Acta 1612(1): 117-121
Vassileva-Atanassova, A.; Mironova, R.; Nacheva, G.; Ivanov, I. 1999: N-terminal methionine in recombinant proteins expressed in two different Escherichia coli strains. Journal of Biotechnology 69(1): 63-67
Dummitt, B.; Micka, W.S.; Chang, Y.-H. 2003: N-terminal methionine removal and methionine metabolism in Saccharomyces cerevisiae. Journal of Cellular Biochemistry 89(5): 964-974
Wang, Z.Yu.; Shimonaga, M.; Kobayashi, M.; Nozawa, T. 2002: N-terminal methylation of the core light-harvesting complex in purple photosynthetic bacteria. FEBS Letters 519(1-3): 164-168
Tsubery, H.; Ofek, I.; Cohen, S.; Fridkin, M. 2001: N-terminal modifications of polymyxin B nonapeptide and their effect on antibacterial activity. Peptides 22(10): 1675-1681
Saviranta PJauria, P.; Lamminmäki, U.; Hellman, J.; Eriksson, S.; Lövgren, T. 2000: N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties. Protein Science: a Publication of the Protein Society 9(12): 2547-2556
De Falco, S.; Ruvo, M.; Verdoliva, A.; Scarallo, A.; Raimondo, D.; Raucci, A.; Fassina, G. 2001: N-terminal myristylation of HBV preS1 domain enhances receptor recognition. Journal of Peptide Research: Official Journal of the American Peptide Society 57(5): 390-400
Zhang, X.; Jin, Q.K.; Carr, S.A.; Annan, R.S. 2002: N-Terminal peptide labeling strategy for incorporation of isotopic tags: a method for the determination of site-specific absolute phosphorylation stoichiometry. Rapid Communications in Mass Spectrometry: Rcm 16(24): 2325-2332
Tanaka, T.; Yada, R.Y. 2001: N-terminal portion acts as an initiator of the inactivation of pepsin at neutral pH. Protein Engineering 14(9): 669-674
Fisher, C.; Berry, C.; Blue, L.; Morton, J.J.; McMurray, J. 2003: N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 89(8): 879-881
Jernberg, T.; Stridsberg, M.; Venge, P.; Lindahl, B. 2002: N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. Journal of the American College of Cardiology 40(3): 437-445
Omland, Tørn.; Persson, A.; Ng, L.; O'Brien, R.; Karlsson, T.; Herlitz, J.; Hartford, M.; Caidahl, K. 2002: N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106(23): 2913-2918
Luchner, A.; Hengstenberg, C.; Löwel, H.; Trawinski, J.ür.; Baumann, M.; Riegger, G.ün.A.J.; Schunkert, H.; Holmer, S. 2002: N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 39(1): 99-104
James, S.K.; Lindahl, B.; Siegbahn, A.; Stridsberg, M.; Venge, P.; Armstrong, P.; Barnathan, E.S.; Califf, R.; Topol, E.J.; Simoons, M.L.; Wallentin, L. 2003: N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108(3): 275-281
Fruhwald, F.M.; Fahrleitner, A.; Watzinger, N.; Dobnig, H.; Schumacher, M.; Maier, R.; Zweiker, R.; Leb, G.; Klein, W. 1999: N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy. Heart 82(5): 630-633
Klinge, R.; Jørgensen, B.; Thaulow, E.; Sirnes, P.A.; Hall, C. 1999: N-terminal proatrial natriuretic peptide in angina pectoris: Impact of revascularization by angioplasty. International Journal of Cardiology 68(1): 1-8
Hall, C.; Ihlen, H.; Bonarjee, V.; Dickstein, K.; Kjekshus, J. 2003: N-terminal proatrial natriuretic peptide in primary care: Relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease. International Journal of Cardiology 89(2-3): 197-205
Cho, E.G.; Kim, M.G.; Kim, C.; Kim, S.R.; Seong, I.S.; Chung, C.; Schwartz, R.H.; Park, D. 2001: N-terminal processing is essential for release of epithin, a mouse type Ii membrane serine protease. Journal of Biological Chemistry 276(48): 44581-44589
Mccabe, J.B.; Berthiaume, L.G. 2001: N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae. Molecular Biology of the Cell 12(11): 3601-3617
Fasciotto, B.H.; Cohn, D.V.; Gorr, S.U.rik 2002: N-terminal proteolytic processing of porcine chromogranin A in parathyroid tissue. Regulatory Peptides 103(1): 53-58, 15 January
Raha, T.; Samal, E.; Majumdar, A.; Basak, S.; Chattopadhyay, D.; Chattopadhyay, D.J. 2000: N-terminal region of P protein of Chandipura virus is responsible for phosphorylation-mediated homodimerization. Protein Engineering 13(6): 437-444
Takami, Y.; Nakayama, T. 2000: N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line. Journal of Biological Chemistry 275(21): 16191-16201
Clark, K.D.; Volkman, B.F.; Thoetkiattikul, H.; Hayakawa, Y.; Strand, M.R. 2001: N-terminal residues of plasmatocyte-spreading peptide possess specific determinants required for biological activity. Journal of Biological Chemistry 276(40): 37431-37435
Richter, K.; Reinstein, J.; Buchner, J. 2002: N-terminal residues regulate the catalytic efficiency of the Hsp90 ATPase cycle. Journal of Biological Chemistry 277(47): 44905-44910
Mahnke-Zizelman, D.K.; Sabina, R.L. 2002: N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform e. Journal of Biological Chemistry 277(45): 42654-42662
Orlovsky, K.; Ben-Dor, I.; Priel-Halachmi, S.; Malovany, H.; Nir, U. 2000: N-terminal sequences direct the autophosphorylation states of the FER tyrosine kinases in vivo. Biochemistry 39(36): 11084-11091
Schuurmans Stekhoven, F.M.; Flik, G.; Wendelaar Bonga, S.E. 2001: N-terminal sequences of small ion channels in rectal glands of sharks: a biochemical hallmark for classification and phylogeny?. Biochemical and Biophysical Research Communications 288(3): 670-675
Yamaguchi, Y.; Katoh, H.; Negishi, M. 2003: N-terminal short sequences of alpha subunits of the G12 family determine selective coupling to receptors. Journal of Biological Chemistry 278(17): 14936-14939
Lee, H.; Jang, I.Ho.; Ryu, S.Ho.; Park, T.Gwan. 2003: N-terminal site-specific mono-PEGylation of epidermal growth factor. Pharmaceutical Research 20(5): 818-825
Dautzenberg, F.M.; Mevenkamp, G.; Wille, S.; Hauger, R.L. 1999: N-terminal splice variants of the type I PACAP receptor: Isolation, characterization and ligand binding/selectivity determinants. Journal of Neuroendocrinology 11(12): 941-949
Lee, S.Y.; Pohajdak, B. 2000: N-terminal targeting of guanine nucleotide exchange factors (GEF) for ADP ribosylation factors (ARF) to the Golgi. Journal of Cell Science 113: 1883-1889
Luciano, R.L.; Wilson, A.C. 2000: N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the host cell factor-1 binding motif. Proceedings of the National Academy of Sciences of the United States of America 97(20): 10757-10762
Chan, K.W.; Zhang, H.; Logothetis, D.E. 2003: N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO Journal 22(15): 3833-3843
Guan, J.; Krishnamurthi, R.; Waldvogel, H.J.; Faull, R.L.; Clark, R.; Gluckman, P. 2000: N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Research 859(2): 286-292
Shumyantseva, V.V.; Bulko, T.V.; Alexandrova, S.A.; Sokolov, N.N.; Schmid, R.D.; Bachmann, T.; Archakov, A.I. 1999: N-terminal truncated cytochrome P450 2B4: catalytic activities and reduction with alternative electron sources. Biochemical and Biophysical Research Communications 263(3): 678-680
Noordzij, J.G.; Verkaik, N.S.; Hartwig, N.G.; de Groot, R.; van Gent, D.C.; van Dongen, J.J. 2000: N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. Blood 96(1): 203-209
Pupo, A.S.; Uberti, M.A.; Minneman, K.P. 2003: N-terminal truncation of human alpha1D-adrenoceptors increases expression of binding sites but not protein. European Journal of Pharmacology 462(1-3): 1-8
Lawson, V.A.; Priola, S.A.; Wehrly, K.; Chesebro, B. 2001: N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. Journal of Biological Chemistry 276(38): 35265-35271
Granas, C.; Ferrer, J.; Loland, C.J.; Javitch, J.A.; Gether, U. 2003: N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. Journal of Biological Chemistry 278(7): 4990-5000
Ippolito, D.L.; Temkin, P.A.; Rogalski, S.L.; Chavkin, C. 2002: N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. Journal of Biological Chemistry 277(36): 32692-32696
Ito, K.; Adachi, S.; Iwakami, R.; Yasuda, H.; Muto, Y.; Seki, N.; Okano, Y. 2001: N-terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8. European Journal of Biochemistry 268(9): 2725-2732
O'Harte, F.P.; Mooney, M.H.; Lawlor, A.; Flatt, P.R. 2000: N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo. Biochimica et Biophysica Acta 1474(1): 13-22
Kranewitter, W.J.; Gimona, M. 1999: N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells. FEBS Letters 455(1-2): 123-129
Mariniello, L.; Esposito, C.; Caputo, I.; Sorrentino, A.; Porta, R. 2003: N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding. International Journal of Biochemistry and Cell Biology 35(7): 1098-1108
Liu, W.; Li, H.; Chen, Y-Hua. 2003: N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunology and Medical Microbiology 35(2): 141-146
Plotz, G.; Raedle, J.; Brieger, A.; Trojan, Jörg.; Zeuzem, S. 2003: N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha. Nucleic Acids Research 31(12): 3217-3226
Mukhija, R.; Garg, L.C. 1999: N-terminus of mature heat-labile enterotoxin chain B is critical for its extracellular secretion in Vibrio cholerae. FEBS Letters 463(3): 336-340
Yeh, S.Y. 1999: N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse 31(3): 169-177
Roos, M.W.; Ericsson, A. 1999: N-tert-butyl-alpha-phenylnitrone reduces the number of microinfarctions in the rabbit brain cortex. Experimental Brain Research 124(2): 271-272
Milivojevic, N.; Babic, K.; Milatovic, D.; Dettbarn, W.D.; Sket, D.; Zivin, M. 2001: N-tert-butyl-alpha-phenylnitrone, a free radical scavenger with anticholinesterase activity does not improve the cognitive performance of scopolamine-challenged rats. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 19(3): 319-325
Yang, G.X.; Chang, L.L.; Truong, Q.; Doherty, G.A.; Magriotis, P.A.; de Laszlo, S.E.; Li, B.; MacCoss, M.; Kidambi, U.; Egger, L.A.; McCauley, E.; Van Riper, G.; Mumford, R.A.; Schmidt, J.A.; Hagmann, W.K. 2002: N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists. Bioorganic and Medicinal Chemistry Letters 12(11): 1497-1500
Turos, E.; Long, T.E.; Konaklieva, M.I.; Coates, C.; Shim, J.Yeop.; Dickey, S.; Lim, D.V.; Cannons, A. 2002: N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus. Bioorganic and Medicinal Chemistry Letters 12(16): 2229-2231
Turos, E.; Konaklieva, M.I.; Ren, R.X.F.; Shi, H.; Gonzalez, J.; Dickey, S.; Lim, D. 2000: N-thiolated bicyclic and monocyclic beta-lactams. Tetrahedron 56(31): 5571-5578, 28 July
Gutheil, W.G.; Xu, Q. 2002: N-to-C solid-phase peptide and peptide trifluoromethylketone synthesis using amino acid tert-butyl esters. Chemical and Pharmaceutical Bulletin 50(5): 688-691
Leblanc, M.H.; Feng, Y.; Fratkin, J.D. 2000: N-tosyl-L-phenylalanyl-chloromethylketone reduces hypoxic-ischemic brain injury in rat pups. European Journal of Pharmacology 390(3): 249-256
Thanou, M.; Florea, B.I.; Langemeÿer, M.W.; Verhoef, J.C.; Junginger, H.E. 2000: N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharmaceutical Research 17(1): 27-31
Kurihara, T.; Tanabe, T. 2003: N-type Ca2+ channel. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 121(4): 211-222
Liu, J.; Evans, M.S.; Brewer, G.J.; Lee, T.J. 2000: N-type Ca2+ channels in cultured rat sphenopalatine ganglion neurons: an immunohistochemical and electrophysiological study. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 20(1): 183-191
Johri, A.M.; Janssen, L.J. 1999: N-Type Ca(2+) channels trigger release of excitatory and inhibitory neurotransmitter from nerve endings in canine bronchi. Journal of Pharmacology and Experimental Therapeutics 290(2): 847-853
Beuckmann, C.T.; Sinton, C.M.; Miyamoto, N.; Ino, M.; Yanagisawa, M. 2003: N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(17): 6793-6797
Haubrich, C.; Frielingsdorf, V.; Herzig, S.; Schröder, H.; Schwarting, R.; Sturm, V.; Voges, J. 2000: N-type calcium channel blockers - tools for modulation of cerebral functional units?. Brain Research 855(2): 225-234
Jones, L.P.; DeMaria, C.D.; Yue, D.T. 1999: N-type calcium channel inactivation probed by gating-current analysis. Biophysical Journal 76(5): 2530-2552
Vance, C.L.; Begg, C.M.; Lee, W.L.; Dubel, S.J.; Copeland, T.D.; Sönnichsen, F.D.; McEnery, M.W. 1999: N-type calcium channel/syntaxin/SNAP-25 complex probed by antibodies to II-III intracellular loop of the alpha1B subunit. Neuroscience 90(2): 665-676
Elmslie, K.S. 2000: N-type calcium channels. Korean Journal of Physiology and Pharmacology 4(6): 427-437
Sun, B.B.; Chiu, S.Y. 1999: N-type calcium channels and their regulation by GABAB receptors in axons of neonatal rat optic nerve. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(13): 5185-5194
Molderings, G.J.; Likungu, J.; Göthert, M. 2000: N-Type calcium channels control sympathetic neurotransmission in human heart atrium. Circulation 101(4): 403-407
Tredway, T.L.; Guo, J.Z.; Chiappinelli, V.A. 1999: N-type voltage-dependent calcium channels mediate the nicotinic enhancement of GABA release in chick brain. Journal of Neurophysiology 81(2): 447-454
Ding, K.; Jonsson, M.; Mani, K.; Sandgren, S.; Belting, M.; Fransson, L.A. 2001: N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein. Journal of Biological Chemistry 276(6): 3885-3894
Korzh, V.P.; Dobrovolsakya-Zavadskaya, N.A. 2001: N.A. Dobrovolskaya-Zavadskaya and the discovery of the T gene. Ontogenez 32(3): 234-237
Schirbel, A.; Holschbach, M.H.; Coenen, H.H. 1999: N.C.A (11C)CO2 as a safe substitute for phosgene in the carbonylation of primary amines. Journal of Labelled Compounds and Radiopharmaceuticals 42(6): 537-551
Mirzoian, E.N. 2002: N.K. Kol'tsov's theory of synthetic biology. Ontogenez 33(2): 142-149
Ford, J.M.; Mathalon, D.H.; Kalba, S.; Marsh, L.; Pfefferbaum, A. 2001: N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features. Biological Psychiatry 49(10): 848-860
Tyacke, R.J.; Robinson, E.S.J.; Schnabel, R.; Lewis, J.W.; Husbands, S.M.; Nutt, D.J.; Hudson, A.L. 2002: N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. Nuclear Medicine and Biology 29(4): 455-462
Li, W.S.; Zhang, N.; Sayre, L.M. 2001: N1,N10-ethylene-bridged high-potential flavins: Synthesis, characterization, and reactivity. Tetrahedron 57(21): 4507-4522
Tsai, Y.; Dukat, M.; Slassi, A.; MacLean, N.; Demchyshyn, L.; Savage, J.E.; Roth, B.L.; Hufesein, S.; Lee, M.; Glennon, R.A. 2000: N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists. Bioorganic and Medicinal Chemistry Letters 10(20): 2295-2299
Dauban, P.; Ferry, S.; Faure, H.; Ruat, M.; Dodd, R.H. 2000: N1-Arylsulfonyl-N2-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor. Bioorganic and Medicinal Chemistry Letters 10(17): 2001-2004
Tan, D.X.; Manchester, L.C.; Burkhardt, S.; Sainz, R.M.; Mayo, J.C.; Kohen, R.; Shohami, E.; Huo, Y.S.; Hardeland, R.; Reiter, R.J. 2001: N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB Journal 15(12): 2294-2296
Young, K.A.; Smith, M.; Rawls, T.; Elliott, D.B.; Russell, I.S.; Hicks, P.B. 2001: N100 evoked potential latency variation and startle in schizophrenia. Neuroreport 12(4): 767-773
Hirose, H.; Kubota, M.; Kimura, I.; Yumoto, M.; Sakakihara, Y. 2003: N100m in children possessing absolute pitch. Neuroreport 14(6): 899-903
Mori, M.; Nakagami, H.; Morishita, R.; Mitsuda, N.; Yamamoto, K.; Yoshimura, S-ichi.; Ohkubo, N.; Sato, N.; Ogihara, T.; Kaneda, Y. 2002: N141I mutant presenilin-2 gene enhances neuronal cell death and decreases bcl-2 expression. Life Sciences 70(21): 2567-2580
Sonoo, M.; Tsai-Shozawa, Y.; Aoki, M.; Nakatani, T.; Hatanaka, Y.; Mochizuki, A.; Sawada, M.; Kobayashi, K.; Shimizu, T. 1999: N18 in median somatosensory evoked potentials: a new indicator of medullary function useful for the diagnosis of brain death. Journal of Neurology Neurosurgery and Psychiatry 67(3): 374-378
Mayeux, V.ér.; Corcia, P.; Besson, G.ér.; Jafari-Schluep, H.él.èn.-F.; Briolotti, V.ér.; Camu, W. 2003: N19S, a new SOD1 mutation in sporadic amyotrophic lateral sclerosis: no evidence for disease causation. Annals of Neurology 53(6): 815-818
Bordt, S.L.; McKeon, R.M.; Li, P.K.; Witt-Enderby, P.A.; Melan, M.A. 2001: N1E-115 mouse neuroblastoma cells express mt1 melatonin receptors and produce neurites in response to melatonin. Biochimica et Biophysica Acta 1499(3): 257-264
Demiralp, T.; Uçok, A.; Devrim, Müge.; Isoglu-Alkaç, Uühan.; Tecer, A.; Polich, J. 2002: N2 and P3 components of event-related potential in first-episode schizophrenic patients: Scalp topography, medication, and latency effects. Psychiatry Research 111(2-3): 167-179
Gallon, J.R. 2001: N2 fixation in phototrophs: Adaptation to a specialized way of life. Plant and Soil 230(1): 39-48
Krishna, C.M.; Bose, B.; Gupta, P.K. 2000: N2 laser-induced oxidation of hemoproteins in red blood cell lysate. Radiation Research 153(4): 411-415
Cartaxana, P.; Lloyd, D. 1999: N2, N2O and O2 profiles in a Tagus estuary salt marsh. Estuarine Coastal and Shelf Science 48(6): 751-756
Schneider, M.; Quistad, G.B.; Casida, J.E. 1998: N2,7-bis(1-hydroxy-2-oxopropyl)-2'-deoxyguanosine: identical noncyclic adducts with 1,3-dichloropropene epoxides and methylglyoxal. Chemical Research in Toxicology 11(12): 1536-1542
Pischetsrieder, M.; Seidel, W.; Münch, G.; Schinzel, R. 1999: N(2)-(1-Carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies. Biochemical and Biophysical Research Communications 264(2): 544-549
Deras, M.L.; Chittur, S.V.; Davisson, V.J. 1999: N2-hydroxyguanosine 5'-monophosphate is a time-dependent inhibitor of Escherichia coli guanosine monophosphate synthetase. Biochemistry 38(1): 303-310
Sodum, R.S.; Fiala, E.S. 1998: N2-amination of guanine to 2-hydrazinohypoxanthine, a novel in vivo nucleic acid modification produced by the hepatocarcinogen 2-nitropropane. Chemical Research in Toxicology 11(12): 1453-1459
Yee, Y.K.; Tebbe, A.L.; Linebarger, J.H.; Beight, D.W.; Craft, T.J.; Gifford-Moore, D.; Goodson, T.; Herron, D.K.; Klimkowski, V.J.; Kyle, J.A.; Sawyer, J.S.; Smith, G.F.; Tinsley, J.M.; Towner, R.D.; Weir, L.; Wiley, M.R. 2000: N(2)-Aroylanthranilamide inhibitors of human factor Xa. Journal of Medicinal Chemistry 43(5): 873-882
Fernández-Valiente, E..; Quesada, A..; Howard-Williams, C..; Hawes, I.. 2001: N2-Fixation in Cyanobacterial Mats from Ponds on the McMurdo Ice Shelf, Antarctica. Microbial Ecology 42(3): 338-349
Olson; Steppe; Litaker; Paerl 1998: N2-fixing microbial consortia associated with the ice cover of Lake Bonney, Antarctica. Microbial Ecology 36(3): 231-238
Coruzzi, G.; Crawford, N.; Bush, D.; Mishra, B.; Shasha, D. 2002: N2010. Nitrogen Networks in Plants. Plant Physiology (Rockville) 129(2): 398-399
Liu, J.; Wang, J.; Li, Z.; Yu, J.; Zhang, X.; Wang, C.; Wang, Y. 2003: N2O concentration and its emission characteristics in Sanjiang plain wetland. Huan Jing Ke Xue= Huanjing Kexue 24(1): 33-39
X.W.nbin; Hong Yetang; Chen Xuhui; Wang Yu 2000: N2O emission from upland soils in Guizhou and its environmental controlling factors. Huanjing Kexue 21(1): 7-11
Dong, Y. She; Scharffe, Dieter; Domroes, Manfred; Qi, Y.C.; Zhang, Shen 2000: N2O emissions from agricultural soils in the North China Plain: The effect of chemical nitrogen fertilizer and organic manure. Journal of Environmental Sciences 12(4): 463-468
Germon, J.-Claude; Henault, C.; Garrido, F.; Reau, R. 1999: N2O emissions on an agricultural scale: Mechanisms, regulation and possibilities for mitigation. Comptes Rendus de l'Academie d'Agriculture de France 85(6): 148-162
Usui, T.; Koike, I.; Ogura, N. 2001: N2O production, nitrification and denitrification in an estuarine sediment. Estuarine Coastal and Shelf Science 52(6): 769-781
Ishikawa, M.; Quock, R.M. 2003: N(2)O stimulates NOS enzyme activity in C57BL/6 but not DBA/2 mice. Brain Research 976(2): 262-263
Waberski, T.D.; Buchner, H.; Perkuhn, M.; Gobbelé, R.; Wagner, M.; Kücker, W.; Silny, J. 1999: N30 and the effect of explorative finger movements: A model of the contribution of the motor cortex to early somatosensory potentials. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 110(9): 1589-1600
Le, Y.; Jiang, S.; Hu, J.; Gong, W.; Su, S.; Dunlop, N.M.; Shen, W.; Li, B.; Ming Wang, J. 2000: N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes. Clinical Immunology 96(3): 236-242
Alexeeva, I.; Palchikovskaya, L.; Shalamay, A.; Nosach, L.; Zhovnovataya, V.; Povnitsa, O.; Dyachenko, N. 2000: N4-amino-acid derivatives of 6-azacytidine: structure-activity relationship. Acta Biochimica Polonica 47(1): 95-101
Shi, J.; Mathew, J.S.; Tharnish, P.M.; Rachakonda, S.; Pai, S.Balakrishna.; Adams, M.; Grier, J.P.; Gallagher, K.; Zhang, H.; Wu, J-Tao.; Shi, G.; Geleziunas, R.; Erickson-Viitanen, S.; Stuyver, L.; Otto, M.J.; Watanabe, K.A.; Schinazi, R.F. 2003: N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity. Antiviral Chemistry and ChemoTherapy 14(2): 81-90
Hokama, H.; Hiramatsu, K-Ichi.; Wang, J.; O'Donnell, B.F.; Ogura, C. 2003: N400 abnormalities in unmedicated patients with schizophrenia during a lexical decision task. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 48(1): 1-10
Mathalon, D.H.; Faustman, W.O.; Ford, J.M. 2002: N400 and automatic semantic processing abnormalities in patients with schizophrenia. Archives of General Psychiatry 59(7): 641-648
Silva-Pereyra, J.; Harmony, T.; Villanueva, G.; Fernández, T.; Rodríguez, M.; Galán, L.; Díaz-Comas, L.; Bernal, J.; Fernández-Bouzas, A.; Marosi, E.; Reyes, A. 1999: N400 and lexical decisions: Automatic or controlled processing?. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 110(5): 813-824
Halgren, E.; Dhond, R.P.; Christensen, N.; Van Petten, C.; Marinkovic, K.; Lewine, J.D.; Dale, A.M. 2002: N400-like magnetoencephalography responses modulated by semantic context, word frequency, and lexical class in sentences. NeuroImage 17(3): 1101-1116
Harvey, K.F.; Shearwin-Whyatt, L.M.; Fotia, A.; Parton, R.G.; Kumar, S. 2002: N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein. Journal of Biological Chemistry 277(11): 9307-9317
Brar, A.K.; Kanda, Y.; Kessler, C.A.; Cedars, M.I.; Handwerger, S. 1999: N5 endometrial stromal cell line: A model system to study decidual prolactin gene expression. In Vitro Cellular and Developmental Biology. Animal 35(3): 150-154
Sackett, D.L.; Ruvinov, S.B.; Thompson, J. 1999: N5-(L-1-carboxyethyl)-L-ornithine synthase: physical and spectral characterization of the enzyme and its unusual low pKa fluorescent tyrosine residues. Protein Science: a Publication of the Protein Society 8(10): 2121-2129
van Tilburg, E.W.; von Frijtag Drabbe Künzel, J.; de Groote, M.; Vollinga, R.C.; Lorenzen, A.; IJzerman, A.P. 1999: N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. Journal of Medicinal Chemistry 42(8): 1393-1400
Borowicz, K.K.; Kleinrok, Z.; Czuczwar, S.J. 2000: N(6)-2-(4-aminophenyl)ethyl-adenosine enhances the anticonvulsive action of conventional antiepileptic drugs in the kindling model of epilepsy in rats. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 10(4): 237-243
Volpini, R.; Costanzi, S.; Lambertucci, C.; Taffi, S.; Vittori, S.; Klotz, K.-N.; Cristalli, G. 2002: N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands. Journal of Medicinal Chemistry 45(15): 3271-3279
Hanus, J.; Siglerova, V.; Matucha, M. 2000: N6-alkyladenosines and adenines labelled with tritium. Journal of Labelled Compounds and Radiopharmaceuticals 43(5): 523-531
Beukers, M.W.; Wanner, M.J.; Von Frijtag Drabbe Künzel, J.K.; Klaasse, E.C.; IJzerman, A.P.; Koomen, G-Jan. 2003: N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor. Journal of Medicinal Chemistry 46(8): 1492-1503
Hatse, S.; Naesens, L.; De Clercq, E.; Balzarini, J. 1999: N6-cyclopropyl-PMEDAP: A novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties. Biochemical Pharmacology 58(2): 311-323
Olsen, A.; Siboska, G.E.; Clark, B.F.; Rattan, S.I. 1999: N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochemical and Biophysical Research Communications 265(2): 499-502
Jeong, L.S.; Jin, D.Z.; Kim, H.O.; Shin, D.H.; Moon, H.R.; Gunaga, P.; Chun, M.W.; Kim, Y.-C.; Melman, N.; Gao, Z.-G.; Jacobson, K.A. 2003: N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor. Journal of Medicinal Chemistry 46(18): 3775-3777
Gao, Z-Guo.; Blaustein, J.B.; Gross, A.S.; Melman, N.; Jacobson, K.A. 2003: N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors. Biochemical Pharmacology 65(10): 1675-1684
Koivisto, P.; Peltonen, K. 2001: N7-guanine adducts of the epoxy metabolites of 1,3-butadiene in mice lung. Chemico-Biological Interactions 135-136: 363-372
D'costa, M.; Kumar, V.A.; Ganesh, K.N. 2003: N7-guanine as a C+ mimic in hairpin aeg/aepPNA-DNA triplex: Probing binding selectivity by UV-Tm and kinetics by fluorescence-based strand-invasion assay. Journal of Organic Chemistry 68(11): 4439-4445
Cheung, N.K.; Kushner, B.H.; LaQuaglia, M.; Kramer, K.; Gollamudi, S.; Heller, G.; Gerald, W.; Yeh, S.; Finn, R.; Larson, S.M.; Wuest, D.; Byrnes, M.; Dantis, E.; Mora, J.; Cheung, I.Y.; Rosenfield, N.; Abramson, S.; O'Reilly, R.J. 2001: N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Medical and Pediatric Oncology 36(1): 227-230
Berry, M.D. 1999: N8-acetyl spermidine protects rat cerebellar granule cells from low K+-induced apoptosis. Journal of Neuroscience Research 55(3): 341-351
Dong-Yue-Sheng; Zheng-Zhi-Hui; Zhang-Qian; Zhang-Hua; Lu-Xin-Hua; Shu-Wei; Shan-Yue-Qi; Ma-Ying; Mu-Ya-Mei; He-Bing-Kun 2002: N98-1021 A, a selective acetylcholinesterase inhibitors derived from microorganisms. Zhongguo Kangshengsu Zazhi 27(5): 260-263
Montes, M.-De-Jesus-Flores; De-Macedo, S.-Jose; Koening, M.-Luise 2002: N:Si:P atomic ratio in the Santa Cruz Channel, Itamaraca-PE (Northeast Brazil): A nyctemeral variation. Brazilian Archives of Biology and Technology 45(2): 115-124
Abid, S.; Nsiri, B.; Sall, A.; Joudi, K.; Jenhani, F.; Boukef, K. 2000: NA antigen frequencies in the Tunisian population. Pathologie-Biologie 48(6): 562-565
Kaplya, A.A.; Mishchuk, D.O. 2001: NA+, K+-ATP-ase isoenzymes of the excitable tissues under pathological states. Ukrainskii Biokhimicheskii Zhurnal 73(5): 17-22
Kawada, M.; Kuwahara, A.; Nishikiori, T.; Mizuno, S.; Uehara, Y. 1999: NA22598, a novel antitumor compound, reduces cyclin D1 levels, arrests cell cycle at G1 phase, and inhibits anchorage-independent growth of human tumor cells. Experimental Cell Research 249(2): 240-247
Wald, L.L.; Frederick, B.; Renshaw, P.F. 1999: NAA-weighted imaging of the human brain using a conventional readout gradient. Magnetic Resonance in Medicine 41(1): 187-192
Moccia, F.; Lim, D.; Nusco, G.A.; Ercolano, E.; Santella, L. 2003: NAADP activates a Ca2+ current that is dependent on F-actin cytoskeleton. FASEB Journal 17(13): 1907-1909
Churchill, G.C.; Galione, A. 2001: NAADP induces Ca2+ oscillations via a two-pool mechanism by priming IP3- and cADPR-sensitive Ca2+ stores. EMBO Journal 20(11): 2666-2671
Bak, J.; Billington, R.A.; Timar, G.; Dutton, A.C.; Genazzani, A.A. 2001: NAADP receptors are present and functional in the heart. Current Biology: Cb 11(12): 987-990
Masgrau, R.; Churchill, G.C.; Morgan, A.J.; Ashcroft, S.J.H.; Galione, A. 2003: NAADP: a new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells. Current Biology: Cb 13(3): 247-251
Genazzani, A.A.; Billington, R.A. 2002: NAADP: An atypical Ca2+-release messenger?. Trends in Pharmacological Sciences 23(4): 165-167
Witkin, J.M.; Gasior, M.; Schad, C.; Zapata, A.; Shippenberg, T.; Hartman, T.; Slusher, B.S. 2002: NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology 43(3): 348-356
Thomas, A.G.; Corse, A.M.; Coccia, C.F.; Bilak, M.M.; Rothstein, J.D.; Slusher, B.S. 2003: NAALADase inhibition protects motor neurons against chronic glutamate toxicity. European Journal of Pharmacology 471(3): 177-184
Rogers, S.M.; Miller, H.G.; Miller, W.C.; Zenilman, J.M.; Turner, C.F. 2002: NAAT-identified and self-reported gonorrhea and chlamydial infections: different at-risk population subgroups?. Sexually Transmitted Diseases 29(10): 588-596
Lucerna, M.; Mechtcheriakova, D.; Kadl, A.; Schabbauer, G.; Schäfer, R.; Gruber, F.; Koshelnick, Y.; Müller, H.-D.; Issbrücker, K.; Clauss, M.; Binder, B.R.; Hofer, E. 2003: NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. Journal of Biological Chemistry 278(13): 11433-11440
Correa, R.G.; de Carvalho, A.F.; Pinheiro, N.A.; Simpson, A.J.; de Souza, S.J. 2000: NABC1 (BCAS1): alternative splicing and downregulation in colorectal tumors. Genomics 65(3): 299-302
Simpson, B.M.; Custovic, A.; Simpson, A.; Hallam, C.L.; Walsh, D.; Marolia, H.; Campbell, J.; Woodcock, A. 2001: NAC Manchester Asthma and Allergy Study (NACMAAS): Risk factors for asthma and allergic disorders in adults. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(3): 391-399
Mackler, S.A.; Korutla, L.; Cha, X.Y.; Koebbe, M.J.; Fournier, K.M.; Bowers, M.S.; Kalivas, P.W. 2000: NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(16): 6210-6217
Oiry, J.; Mialocq, P.; Puy, J.Y.; Fretier, P.; Clayette, P.; Dormont, D.; Imbach, J.L. 2001: NAC/MEA conjugate: A new potent antioxidant which increases the GSH level in various cell lines. Bioorganic and Medicinal Chemistry Letters 11(9): 1189-1191
Korutla, L.; Neustadter, J.H.; Fournier, K.M.; Mackler, S.A. 2003: NAC1, a POZ/BTB protein present in the adult mammalian brain, triggers apoptosis after adenovirus-mediated overexpression in PC-12 cells. Neuroscience Research 46(1): 33-39
Arima, K.; Mizutani, T.; Alim, M.A.; Tonozuka-Uehara, H.; Izumiyama, Y.; Hirai, S.; Uéda, K. 2000: NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathologica 100(2): 115-121
Yokota, O.; Terada, S.; Ishizu, H.; Tsuchiya, K.; Kitamura, Y.; Ikeda, K.; Uéda, K.; Kuroda, S. 2002: NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathologica 104(4): 333-341
Arima, K.; Uéda, K.; Sunohara, N.; Arakawa, K.; Hirai, S.; Nakamura, M.; Tonozuka-Uehara, H.; Kawai, M. 1998: NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathologica 96(5): 439-444
Yokota, O.; Terada, S.; Ishizu, H.; Ujike, H.; Ishihara, T.; Nakashima, H.; Yasuda, M.; Kitamura, Y.; Uéda, K.; Checler, F.éd.ér.; Kuroda, S. 2002: NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases. Acta Neuropathologica 104(6): 637-648
Wakabayashi, K.; Hayashi, S.; Yoshimoto, M.; Kudo, H.; Takahashi, H. 2000: NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathologica 99(1): 14-20
Ménétrey, J.; Flatau, G.; Stura, E.A.; Charbonnier, J.-B.; Gas, F.; Teulon, J.-M.; Le Du, M.-H.él.èn.; Boquet, P.; Menez, A.é 2002: NAD binding induces conformational changes in Rho ADP-ribosylating clostridium botulinum C3 exoenzyme. Journal of Biological Chemistry 277(34): 30950-30957
Pfister, M.; Ogilvie, A.; da Silva, C.P.; Grahnert, A.; Guse, A.H.; Hauschildt, S. 2001: NAD degradation and regulation of CD38 expression by human monocytes/macrophages. European Journal of Biochemistry 268(21): 5601-5608
Ohno, A.; Oda, S.; Yamazaki, N. 1999: NAD(P)+-NAD(P)H models. 89. Effect of magnesium ion on the stereochemistry in oxidation of NAD(P)H analog. Tetrahedron Letters 40(24): 4577-4580
Pire, C.; Camacho, M., L.; Ferrer, J.; Hough, D., W.; Bonete, M.-Jose 2000: NAD(P)+-glucose dehydrogenase from Haloferax mediterranei: Kinetic mechanism and metal content. Journal of Molecular Catalysis B Enzymatic 10(4): 409-417
Orsomando, G.; Polzonetti, V.; Natalini, P. 2000: NAD(P)(+)-glycohydrolase from human spleen: a multicatalytic enzyme. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 126(1): 89-98
Schräder, T.; Zarnt, G.; Andreesen, J.R. 2001: NAD(P)-dependent aldehyde dehydrogenases induced during growth of Ralstonia eutropha strain Bo on tetrahydrofurfuryl alcohol. Journal of Bacteriology 183(24): 7408-7411
Georgakoudi, I.; Jacobson, B.C.; Müller, M.G.; Sheets, E.E.; Badizadegan, K.; Carr-Locke, D.L.; Crum, C.P.; Boone, C.W.; Dasari, R.R.; Van Dam, J.; Feld, M.S. 2002: NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes. Cancer Research 62(3): 682-687
Shuttleworth, C.William.; Brennan, A.M.; Connor, J.A. 2003: NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(8): 3196-3208
Geiszt, Mós.; Lekstrom, K.; Brenner, S.; Hewitt, S.M.; Dana, R.; Malech, H.L.; Leto, T.L. 2003: NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. Journal of Immunology 171(1): 299-306
Laplante, M-André.; Wu, R.; El Midaoui, A.; de Champlain, J. 2003: NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. Journal of Hypertension 21(5): 927-936
Hamilton, C.A.; Brosnan, M.Julia.; Al-Benna, S.; Berg, G.; Dominiczak, A.F. 2002: NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40(5): 755-762
Liu, J.; Yang, F.; Yang, X-Ping.; Jankowski, M.; Pagano, P.J. 2003: NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arteriosclerosis Thrombosis and Vascular Biology 23(5): 776-782
Lee, H.Seung.; Son, S.Man.; Kim, Y.Ki.; Hong, K.Whan.; Kim, C.Dae. 2003: NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. Life Sciences 72(24): 2719-2730
Krötz, F.; Sohn, H.Young.; Gloe, T.; Zahler, S.; Riexinger, T.; Schiele, T.M.; Becker, B.F.; Theisen, K.; Klauss, V.; Pohl, U. 2002: NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100(3): 917-924
Cai, H.; Li, Z.; Dikalov, S.; Holland, S.M.; Hwang, J.; Jo, H.; Dudley, S.C.; Harrison, D.G. 2002: NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. Journal of Biological Chemistry 277(50): 48311-48317
Stokes, K.Y.; Clanton, E.C.; Russell, J.M.; Ross, C.R.; Granger, D.N. 2001: NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation Research 88(5): 499-505
Adler, A.; Messina, E.; Sherman, B.; Wang, Z.; Huang, H.; Linke, A.; Hintze, T.H. 2003: NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. American Journal of Physiology. Heart and Circulatory Physiology 285(3): H1015-H1022
Griendling, K.K.; Sorescu, D.; Ushio-Fukai, M. 2000: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circulation Research 86(5): 494-501
Harth, V.; Donat, S.; Ko, Y.; Abel, J.; Vetter, H.; Brüning, T. 2000: NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer. Archives of Toxicology 73(10-11): 528-531
Petrat, F.; Pindiur, S.; Kirsch, M.; de Groot, H. 2002: NAD(P)H, a primary target of 1O2 in mitochondria of intact cells. Journal of Biological Chemistry 278(5): 3298-3307
Hori, H.; Ohmori, O.; Matsumoto, C.; Shinkai, T.; Nakamura, J. 2003: NAD(P)H: Quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia. Psychiatry Research 118(3): 235-239
Allen, P.G.; Kolesar, J.M. 2002: NAD(P)H: quinone oxidoreductase enhances proliferation inhibition by 4-hydroxytamoxifen. Anticancer Research 22(3): 1475-1480
Siegel, D.; Ryder, J.; Ross, D. 2001: NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicology Letters 125(1-3): 93-98
Harris, I.R.; Siefken, W.; Beck-Oldach, K.; Wittern, K-Peter.; Pollet, D. 2002: NAD(P)H:quinone reductase activity in human epidermal keratinocytes and reconstructed epidermal models. Skin Pharmacology and Applied Skin Physiology 15(Suppl): 68-73
Riefler, R.Guy.; Smets, B.F. 2002: NAD(P)H:flavin mononucleotide oxidoreductase inactivation during 2,4,6-trinitrotoluene reduction. Applied and Environmental Microbiology 68(4): 1690-1696
Nebert, D.W.; Roe, A.L.; Vandale, S.E.; Bingham, E.; Oakley, G.G. 2002: NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genetics in Medicine: Official Journal of the American College of Medical Genetics 4(2): 62-70
Ross, D.; Kepa, J., K.; Winski, S., L.; Beall, H., D.; Anwar, A.; Siegel, D. 2000: NAD(P)H:quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chemico Biological Interactions 129(1-2): 77-97
Long, D.J.; Waikel, R.L.; Wang, X.J.; Perlaky, L.; Roop, D.R.; Jaiswal, A.K. 2000: NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Research 60(21): 5913-5915
Wang, Y.; Santa-Cruz, K.; DeCarli, C.; Johnson, J.A. 2000: NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiology of Aging 21(4): 525-531
Pink, J.J.; Planchon, S.M.; Tagliarino, C.; Varnes, M.E.; Siegel, D.; Boothman, D.A. 2000: NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. Journal of Biological Chemistry 275(8): 5416-5424
Lafuente, M.J.; Casterad, X.; Trias, M.; Ascaso, C.; Molina, R.; Ballesta, A.; Zheng, S.; Wiencke, J.K.; Lafuente, A. 2000: NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 21(10): 1813-1819
Polzonetti, V.; Orsomando, G.; Micossi, L.; Vita, A.; Egidi, D.; Natalini, P. 2002: NAD+ catabolism in pheochromocytoma rat cells. Journal of Biological Regulators and Homeostatic Agents 16(3): 196-201
Küpper, J.H.; Müller, M.; Wolf, I. 1999: NAD(+) consumption in carcinogen-treated hamster cells overexpressing a dominant negative mutant of poly(ADP-ribose) polymerase. Biochemical and Biophysical Research Communications 265(2): 525-529
Park, I.K.; Kim, J.Y. 2001: NAD+ inhibits the self-splicing of the group i intron. Biochemical and Biophysical Research Communications 281(1): 206-211
Ying, W.; Garnier, P.; Swanson, R.A. 2003: NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochemical and Biophysical Research Communications 308(4): 809-813
Xie, S.X.; Ogawa, J.; Shimizu, S. 1999: NAD(+)-dependent (S)-specific secondary alcohol dehydrogenase involved in stereoinversion of 3-pentyn-2-ol catalyzed by Nocardia fusca AKU 2123. Bioscience Biotechnology and Biochemistry 63(10): 1721-1729
Sriskanda, V.; Moyer, R.W.; Shuman, S. 2001: NAD+-dependent DNA ligase encoded by a eukaryotic virus. Journal of Biological Chemistry 276(39): 36100-36109
Wilkinson, A.; Sayer, H.; Bullard, D.; Smith, A.; Day, J.; Kieser, T.; Bowater, R. 2003: NAD+-dependent DNA ligases of Mycobacterium tuberculosis and Streptomyces coelicolor. Proteins 51(3): 321-326
Bedalov, A.; Hirao, M.; Posakony, J.; Nelson, M.; Simon, J.A. 2003: NAD+-dependent deacetylase Hst1p controls biosynthesis and cellular NAD+ levels in Saccharomyces cerevisiae. Molecular and Cellular Biology 23(19): 7044-7054
Kersten, M.A.; Müller, Y.; Baars, J.J.; Op den Camp, H.J.; van der Drift, C.; Van Griensven, L.J.; Visser, J.; Schaap, P.J. 1999: NAD+-dependent glutamate dehydrogenase of the edible mushroom Agaricus bisporus: biochemical and molecular characterization. Molecular and General Genetics: Mgg 261(3): 452-462
Bricker, A.L.; Cywes, C.; Ashbaugh, C.D.; Wessels, M.R. 2002: NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Molecular Microbiology 44(1): 257-269
Popova, O.V.; Popova, T.N.; Izmailov, S.F. 1999: NAD- and NADP-isocitrate dehydrogenases and glutamate decarboxylase of pea seedlings as affected by saline stress. Fiziologiya Rastenii 46(5): 784-789
Jerning, E.; Rosqvist, S.; Mohell, N. 2002: NAD-299 antagonises 5-HT-stimulated and spiperone-inhibited (35S)GTPgammaS binding in cloned 5-HT1A receptors. Journal of Receptors and Signal Transduction 22(1-4): 483-495
Balducci, E.; Micossi, L.G. 2002: NAD-dependent inhibition of the NAD-glycohydrolase activity in A549 cells. Molecular and Cellular Biochemistry 233(1-2): 127-132
Oh, T.Jeong.; Kim, I.Gyu.; Park, S.Young.; Kim, K.Chan.; Shim, H.Won. 2002: NAD-dependent malate dehydrogenase protects against oxidative damage in Escherichia coli K-12 through the action of oxaloacetate. Environmental Toxicology and Pharmacology 11(1): 9-14
Seman, M.; Adriouch, S.; Scheuplein, F.; Krebs, C.; Freese, D.; Glowacki, G.; Deterre, P.; Haag, F.; Koch-Nolte, F. 2003: NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19(4): 571-582
Tong, X.; Xie, D.; Roth, W.; Reed, J.; Koeffler, H.Phillip. 2003: NADE (p75NTR-associated cell death executor) suppresses cellular growth in vivo. International Journal of Oncology 22(6): 1357-1362
Mukai, J.; Hachiya, T.; Shoji-Hoshino, S.; Kimura, M.T.; Nadano, D.; Suvanto, P.; Hanaoka, T.; Li, Y.; Irie, S.; Greene, L.A.; Sato, T.A. 2000: NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. Journal of Biological Chemistry 275(23): 17566-17570
Liu, Z.; Niwa, O.; Horiuchi, T.; Kurita, R.; Torimitsu, K. 1999: NADH and glutamate on-line sensors using Os-gel-HRP/GC electrodes modified with NADH oxidase and glutamate dehydrogenase. Biosensors and Bioelectronics 14(7): 631-638
Kmita, H.; Budzinska, M.; Michejda, J. 1999: NADH and proteins may use the same pathway to cross the outer membrane in VDAC-depleted mitochondria. Biological Bulletin of Poznan 36(1): 5-15
Plesofsky, N.; Gardner, N.; Videira, A.; Brambl, R. 2000: NADH dehydrogenase in Neurospora crassa contains myristic acid covalently linked to the ND5 subunit peptide. Biochimica et Biophysica Acta 1495(3): 223-230
Matsushita, K.; Otofuji, A.; Iwahashi, M.; Toyama, H.; Adachi, O. 2001: NADH dehydrogenase of Corynebacterium glutamicum. Purification of an NADH dehydrogenase II homolog able to oxidize NADPH. FEMS Microbiology Letters 204(2): 271-276
Yagi, T.; Seo, B.B.; Di Bernardo, S.; Nakamaru-Ogiso, E.; Kao, M.C.; Matsuno-Yagi, A. 2001: NADH dehydrogenases: From basic science to biomedicine. Journal of Bioenergetics and Biomembranes 33(3): 233-242
Pantano, S.; Alber, F.; Lamba, D.; Carloni, P. 2002: NADH interactions with WT- and S94A-acyl carrier protein reductase from Mycobacterium tuberculosis: An ab initio study. Proteins 47(1): 62-68
Lynn, S.; Gurr, J.R.; Lai, H.T.; Jan, K.Y. 2000: NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circulation Research 86(5): 514-519
Wang, S.; Pogue, R.; Morré, D.M.; Morré, D.J.; Morre, D.J. 2001: NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms. Biochimica et Biophysica Acta 1539(3): 192-204
Miramar, M.D.; Costantini, P.; Ravagnan, L.; Saraiva, L.M.; Haouzi, D.; Brothers, G.; Penninger, J.M.; Peleato, M.L.; Kroemer, G.; Susin, S.A. 2001: NADH oxidase activity of mitochondrial apoptosis-inducing factor. Journal of Biological Chemistry 276(19): 16391-16398
Geueke, B.; Riebel, B.; Hummel, W. 2003: NADH oxidase from Lactobacillus brevis: A new catalyst for the regeneration of NAD. Enzyme and Microbial Technology 32(2): 205-211, 3 February
Kotlyar, A.B.; Borovok, N. 2002: NADH oxidation and NAD+ reduction catalysed by tightly coupled inside-out vesicles from Paracoccus denitrificans. European Journal of Biochemistry 269(16): 4020-4024
Campbell, C.E.; Rishpon, J. 2001: NADH oxidation at the honey-comb like structure of active carbon: Coupled to formaldehyde and sorbitol dehydrogenases. Electroanalysis 13(1): 17-20
Deguchi, T.; Matsubara, M.; Nishida, T. 2002: NADH oxidation by manganese peroxidase with or without alpha-hydroxy acid. Bioscience Biotechnology and Biochemistry 66(4): 717-721
Munteanu, F.D.; Dicu, D.; Popescu, I.C.; Gorton, L. 2003: NADH oxidation using carbonaceous electrodes modified with dibenzo-dithia-diazapentacene. Electroanalysis 15(5-6): 383-391
Coulter, E.D.; Shenvi, N.V.; Kurtz, D.M. 1999: NADH peroxidase activity of rubrerythrin. Biochemical and Biophysical Research Communications 255(2): 317-323
Brambilla, L.; Bolzani, D.; Compagno, C.; Carrera, V.; van Dijken, J.P.; Pronk, J.T.; Ranzi, B.M.; Alberghina, L.; Porro, D. 1999: NADH reoxidation does not control glycolytic flux during exposure of respiring Saccharomyces cerevisiae cultures to glucose excess. FEMS microbiology letters 171(2): 133-140
Eto, K.; Suga, S.; Wakui, M.; Tsubamoto, Y.; Terauchi, Y.; Taka, J.; Aizawa, S.; Noda, M.; Kimura, S.; Kasai, H.; Kadowaki, T. 1999: NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca(2+) concentration elevation in glucose-induced insulin secretion. Journal of Biological Chemistry 274(36): 25386-25392
Rao, A.V.; Ramasarma, T. 2000: NADH-dependent decavanadate reductase, an alternative activity of NADP-specific isocitrate dehydrogenase protein. Biochimica et Biophysica Acta 1474(3): 321-330
Trepanier, L.A.; Miller, J.L. 2000: NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 30(12): 1111-1121
Lee, P.L.; Halloran, C.; Cross, A.R.; Beutler, E. 2000: NADH-ferric reductase activity associated with dihydropteridine reductase. Biochemical and Biophysical Research Communications 271(3): 788-795
Guidarelli, A.; Clementi, E.; Brambilla, L.; Cantoni, O. 1999: NADH-Linked substrate-mediated enhancement of mitochondrial calcium accumulation and DNA single-strand breakage elicited by tert-butylhydroperoxide: the source of the cation is a ryanodine-sensitive calcium store. Experimental Cell Research 249(1): 65-69
Sipkema, E.M.; de Koning, W.; Ganzeveld, K.J.; Janssen, D.B.; Beenackers, A.A. 2000: NADH-Regulated metabolic model for growth of Methylosinus trichosporium OB3b. Model presentation, parameter estimation, and model validation. Biotechnology Progress 16(2): 176-188
Barron, J.T.; Gu, L.; Parrillo, J.E. 2000: NADH/NAD redox state of cytoplasmic glycolytic compartments in vascular smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology 279(6): H2872-H2878
Beswick, R.A.; Dorrance, A.M.; Leite, R.; Webb, R.C. 2001: NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38(5): 1107-1111
Cai, H.; Duarte, N.; Wilcken, D.E.; Wang, X.L. 1999: NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. European Journal of Clinical Investigation 29(9): 744-748
Stanger, O.; Renner, W.; Khoschsorur, G.; Rigler, B.; Wascher, T.C. 2001: NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clinical Physiology 21(6): 718-722
Schächinger, V.; Britten, M.B.; Dimmeler, S.; Zeiher, A.M. 2001: NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. European Heart Journal 22(1): 96-101
Ido, Y.; Chang, K.; Woolsey, T.A.; Williamson, J.R. 2001: NADH: sensor of blood flow need in brain, muscle, and other tissues. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 15(8): 1419-1421
Skehel, J.M.; Fearnley, I.M.; Walker, J.E. 1998: NADH:ubiquinone oxidoreductase from bovine heart mitochondria: Sequence of a novel 17.2-kDa subunit. FEBS Letters 438(3): 301-305
Reidl, J.; Schlör, S.; Kraiss, A.; Schmidt-Brauns, J.; Kemmer, G.; Soleva, E. 2000: NADP and NAD utilization in Haemophilus influenzae. Molecular Microbiology 35(6): 1573-1581
Naylor, C.E.; Gover, S.; Basak, A.K.; Cosgrove, M.S.; Levy, H.R.; Adams, M.J. 2001: NADP+ and NAD+ binding to the dual coenzyme specific enzyme Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase: Different interdomain hinge angles are seen in different binary and ternary complexes. Acta Crystallographica. Section D Biological Crystallography 57(Pt 5): 635-648
Chidambaram, N.; Chang, C.F. 1999: NADP+-Dependent internalization of recombinant CD38 in CHO cells. Archives of Biochemistry and Biophysics 363(2): 267-272
Camacho, Mónica.; Rodríguez-Arnedo, Aón.; Bonete, Mía.José. 2002: NADP-dependent isocitrate dehydrogenase from the halophilic archaeon Haloferax volcanii: cloning, sequence determination and overexpression in Escherichia coli. FEMS Microbiology Letters 209(2): 155-160
DeLuna, A.; Avendano, A.; Riego, L.; Gonzalez, A. 2001: NADP-glutamate dehydrogenase isoenzymes of Saccharomyces cerevisiae. Purification, kinetic properties, and physiological roles. Journal of Biological Chemistry 276(47): 43775-43783
Roy, S.O.; Packard, T.T. 1998: NADP-Isocitrate dehydrogenase from Pseudomonas nautica: kinetic constant determination and carbon limitation effects on the pool of intracellular substrates. Applied and Environmental Microbiology 64(12): 4958-4964
Gómez, I.; Merchán, F.; Fernández, E.; Quesada, A. 2002: NADP-malate dehydrogenase from Chlamydomonas: Prediction of new structural determinants for redox regulation by homology modelling. Plant Molecular Biology 48(3): 211-221
Drincovich, M.F.; Casati, P.; Andreo, C.S. 2001: NADP-malic enzyme from plants: a ubiquitous enzyme involved in different metabolic pathways. Febs Letters 490(1-2): 1-6
Shiibashi, T.; Iida, T. 2001: NADPH and NADH serve as electron donor for the superoxide-generating enzyme in tilapia (Oreochromis niloticus) neutrophils. Developmental and Comparative Immunology 25(5-6): 461-465
Bojko, M.; Wieckowski, S. 1999: NADPH and ferredoxin:NADP+ oxidoreductase-dependent reduction of quinones and their reoxidation. Phytochemistry (Oxford) 50(2): 203-208
Gupte, S.A.; Rupawalla, T.; Phillibert, D.; Wolin, M.S. 1999: NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO. American Journal of Physiology 277(6): L1124-L1132
Auchère, F.; Capeillère-Blandin, C. 1999: NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase. Biochemical Journal 343 Pt 3: 603-613
Ryu, J-Youn.; Suh, K-Hong.; Chung, Y-Ho.; Park, Y-Mok.; Chow, W.Soon.; Park, Y-Il. 2003: NADPH dehydrogenase-mediated respiratory electron transport in thylakoid membranes of the cyanobacterium Synechocystis sp. PCC 6803 is inactive in the light. Molecules and Cells 15(2): 240-244
Schoenfeld, T.A.; Knott, T.K. 2002: NADPH diaphorase activity in olfactory receptor neurons and their axons conforms to a rhinotopically-distinct dorsal zone of the hamster nasal cavity and main olfactory bulb. Journal of Chemical Neuroanatomy 24(4): 269-285
Kucharova, K.; Fercakova, A.; Jalc, P.; Marsala, J. 2001: NADPH diaphorase activity in the primary sensory neurons following peripheral axotomy. Biologia (Bratislava) 56(3): 321-328
Zemel, E.; Lei, B.; Perlman, I. 2001: NADPH diaphorase activity in the rabbit retina is modulated by glutamatergic pathways. Journal of Comparative Neurology 431(1): 28-38
Li, Q.; Zemel, E.; Miller, B.; Perlman, I. 2003: NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes. Graefe's Archive for Clinical and Experimental Ophthalmology 241(9): 747-756
Ott, S.R.; Burrows, M. 1999: NADPH diaphorase histochemistry in the thoracic ganglia of locusts, crickets, and cockroaches: Species differences and the impact of fixation. Journal of Comparative Neurology 410(3): 387-397
Schmachtenberg, O.; Bicker, G.; Bacigalupo, J. 2001: NADPH diaphorase is developmentally regulated in rat olfactory epithelium. Neuroreport 12(5): 1039-1043
Wester, T.; O'Briain, S.; Puri, P. 1998: NADPH diaphorase-containing nerve fibers and neurons in the myenteric plexus are resistant to postmortem changes: studies in Hirschsprung's disease and normal autopsy material. Archives of Pathology and Laboratory Medicine 122(5): 461-466
Umanskiy, K.; Robinson, C.; Cave, C.; Williams, M.A.; Lentsch, A.B.; Cuschieri, J.; Solomkin, J.S. 2003: NADPH oxidase activation in fibronectin adherent human neutrophils: A potential role for beta1 integrin ligation. Surgery 134(2): 378-383
Hu, Q.; Zheng, G.; Zweier, J.L.; Deshpande, S.; Irani, K.; Ziegelstein, R.C. 2000: NADPH oxidase activation increases the sensitivity of intracellular Ca2+ stores to inositol 1,4,5-trisphosphate in human endothelial cells. Journal of Biological Chemistry 275(21): 15749-15757
Condino-Neto, A.; Newburger, P.E. 1998: NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Archives of Biochemistry and Biophysics 360(2): 158-164
Lee, V.M.; Quinn, P.A.; Jennings, S.C.; Ng, L.L. 2003: NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models. Hypertension 41(4): 925-931
Sekhar, K.R.; Crooks, P.A.; Sonar, V.N.; Friedman, D.B.; Chan, J.Y.; Meredith, M.J.; Starnes, J.H.; Kelton, K.R.; Summar, S.R.; Sasi, S.; Freeman, M.L. 2003: NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols. Cancer Research 63(17): 5636-5645
Abid, M.R.; Kachra, Z.; Spokes, K.C.; Aird, W.C. 2000: NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Letters 486(3): 252-256
O'Kelly, I.; Peers, C.; Kemp, P.J. 2001: NADPH oxidase does not account fully for O2-sensing in model airway chemoreceptor cells. Biochemical and Biophysical Research Communications 283(5): 1131-1134
Vaissiere, C.; Le Cabec, V.; Maridonneau-Parini, I. 1999: NADPH oxidase is functionally assembled in specific granules during activation of human neutrophils. Journal of Leukocyte Biology 65(5): 629-634
Katsuyama, M.; Fan, C.; Yabe-Nishimura, C. 2002: NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. Journal of Biological Chemistry 277(16): 13438-13442
Herkert, O.; Diebold, I.; Brandes, R.P.; Hess, J.; Busse, R.; Görlach, A. 2002: NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 105(17): 2030-2036
Paclet, M.H.; Coleman, A.W.; Burritt, J.; Morel, F. 2001: NADPH oxidase of Epstein-Barr-virus immortalized B lymphocytes. Effect of cytochrome b(558) glycosylation. European Journal of Biochemistry 268(19): 5197-5208
Bhattacharjee, S.; Pennathur, S.; Byun, J.; Crowley, J.; Mueller, D.; Gischler, J.; Hotchkiss, R.S.; Heinecke, J.W. 2001: NADPH oxidase of neutrophils elevates o,o'-dityrosine cross-links in proteins and urine during inflammation. Archives of Biochemistry and Biophysics 395(1): 69-77
Brar, S.S.; Kennedy, T.P.; Sturrock, A.B.; Huecksteadt, T.P.; Quinn, M.T.; Murphy, T.M.; Chitano, P.; Hoidal, J.R. 2002: NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle. American Journal of Physiology. Lung Cellular and Molecular Physiology 282(4): L782-L795
Bataller, R.; Schwabe, R.F.; Choi, Y.H.; Yang, L.; Paik, Y.H.; Lindquist, J.; Qian, T.; Schoonhoven, R.; Hagedorn, C.H.; Lemasters, J.J.; Brenner, D.A. 2003: NADPH oxidase signal transduces angiotensin Ii in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 112(9): 1383-1394
Henderson, L.M. 2001: NADPH oxidase subunit gp91phox: A proton pathway. Protoplasma 217(1-3): 37-42
Kikuchi, H.; Hikage, M.; Miyashita, H.; Fukumoto, M. 2000: NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene 254(1-2): 237-243
Höhler, B.; Holzapfel, B.; Kummer, W. 2000: NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochemistry and Cell Biology 114(1): 29-37
Matsushita, K.; Yamamoto, T.; Toyama, H.; Adachi, O. 1998: NADPH oxidase system as a superoxide-generating cyanide-resistant pathway in the respiratory chain of Corynebacterium glutamicum. Bioscience Biotechnology and Biochemistry 62(10): 1968-1977
Van Heerebeek, L.; Meischl, C.; Stooker, W.; Meijer, C.J.L.M.; Niessen, H.W.M.; Roos, D. 2002: NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?. Journal of Clinical Pathology 55(8): 561-568
Arroyo, A.; Modrianský, M.; Serinkan, F.B.; Bello, R.I.; Matsura, T.; Jiang, J.; Tyurin, V.A.; Tyurina, Y.Y.; Fadeel, B.; Kagan, V.E. 2002: NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. Journal of Biological Chemistry 277(51): 49965-49975
Kono, H.; Rusyn, I.; Yin, M.; Gäbele, E.; Yamashina, S.; Dikalova, A.; Kadiiska, M.B.; Connor, H.D.; Mason, R.P.; Segal, B.H.; Bradford, B.U.; Holland, S.M.; Thurman, R.G. 2000: NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. Journal of Clinical Investigation 106(7): 867-872
Nakagami, H.; Takemoto, M.; Liao, J.K. 2003: NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 35(7): 851-859
Li, L.; Watts, S.W.; Banes, A.K.; Galligan, J.J.; Fink, G.D.; Chen, A.F. 2003: NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension 42(3): 316-321
Takahashi, K.G.; Mori, K. 2000: NADPH oxidase-like activity in hemocytes of the Pacific oyster Crassostrea gigas. Fish Pathology 35(1): 15-19
Jones, R.D.; Hancock, J.T.; Morice, A.H. 2000: NADPH oxidase: A universal oxygen sensor?. Free Radical Biology and Medicine 29(5): 416-424
Lalucque, Hé.; Silar, P. 2003: NADPH oxidase: an enzyme for multicellularity?. Trends in Microbiology 11(1): 9-12
Babior, B.M. 1999: NADPH oxidase: an update. Blood 93(5): 1464-1476
Bokoch, G.M.; Knaus, U.G. 2003: NADPH oxidases: not just for leukocytes anymore!. Trends in Biochemical Sciences 28(9): 502-508
Spink, D.C.; Spink, B.C.; Zhuo, X.; Hussain, M.M.; Gierthy, J.F.; Ding, X. 2000: NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1. Journal of Steroid Biochemistry and Molecular Biology 74(1-2): 11-18
Osada, M.; Imaoka, S.; Sugimoto, T.; Hiroi, T.; Funae, Y. 2002: NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1. Journal of Biological Chemistry 277(26): 23367-23373
Hubbard, P.A.; Shen, A.L.; Paschke, R.; Kasper, C.B.; Kim, J.J. 2001: NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer. Journal of Biological Chemistry 276(31): 29163-29170
Lamanna, C.; Vittoria, A.; Assisi, L.; Lucini, C.; Castaldo, L.; Botte, V. 2001: NADPH-d positive neurons of the lizard Podarcis s. sicula oviduct and their relationship to 17beta-estradiol hormone. Life Sciences 69(15): 1765-1773
Deng, Y.; Wang, Z.; Ying, K.; Gu, S.; Ji, C.; Huang, Y.; Gu, X.; Wang, Y.; Xu, Y.; Li, Y.; Xie, Y.; Mao, Y. 2002: NADPH-dependent GMP reductase isoenzyme of human (GMPR2). Expression, purification, and kinetic properties. International Journal of Biochemistry and Cell Biology 34(9): 1035-1050
Gaber, A.; Tamoi, M.; Takeda, T.; Nakano, Y.; Shigeoka, S. 2001: NADPH-dependent glutathione peroxidase-like proteins (Gpx-1, Gpx-2) reduce unsaturated fatty acid hydroperoxides in Synechocystis PCC 6803. FEBS Letters 499(1-2): 32-36
Lee, A.J.; Mills, L.H.; Kosh, J.W.; Conney, A.H.; Zhu, B.T. 2002: NADPH-dependent metabolism of estrone by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics 300(3): 838-849
Goasduff, T.; Cederbaum, A.I. 1999: NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species. Archives of Biochemistry and Biophysics 370(2): 258-270
Sato, S.; Secchi, E.Filippo.; Sakurai, S.; Ohta, N.; Fukase, S.; Lizak, M.J. 2003: NADPH-dependent reductases and polyol formation in human leukemia cell lines. Chemico-Biological Interactions 143-144: 363-371
Xue, B.J.; Zhang, X.X.; Ding, Y.F.; Shi, G.M.; He, R.R. 2001: NADPH-diaphorase activity and Fos expression in brainstem nuclei involved in cardiovascular regulation following intracarotid injection of capsaicin. Sheng Li Xue Bao: 53(1): 66-71
Maisky, V.A.; Pilyavskii, A.I.; Kalezic, I.; Ljubisavljevic, M.; Kostyukov, A.I.; Windhorst, U.; Johansson, Håkan. 2002: NADPH-diaphorase activity and c-fos expression in medullary neurons after fatiguing stimulation of hindlimb muscles in the rat. Autonomic Neuroscience: Basic and Clinical 101(1-2): 1-12
Kerschbaum, H.H.; Huang, S.; Xie, M.; Hermann, A. 2000: NADPH-diaphorase activity and nitric oxide synthase activity in the kidney of the clawed frog, Xenopus laevis. Cell and Tissue Research 301(3): 405-411
Moraes, N.; Zago, D.; Gagioti, S.; Hoshida, M.S.; Bevilacqua, E. 2001: NADPH-diaphorase activity and nitric oxide synthase isoforms in the trophoblast of Calomys callosus. Journal of Anatomy 198(Pt 4): 443-453
Chen, S.T.; Wang, J.P.; Shen, C.L.; Jen, L.S. 1999: NADPH-diaphorase activity in normally developing and intracranially transplanted retinas. Neurochemical Research 24(8): 1051-1057
Caballero Bleda, M.; Redondo Aniorte, F.J.; Aldeguer Montiel, A.; Popovic, N.; Popovic, M.; Puelles, L. 2001: NADPH-diaphorase activity in the frontal cortex of NBM-lesioned rats treated with verapamil. Neuroscience Research Communications 28(2): 115-122
Lamanna, C.; Costagliola, A.; Vittoria, A.; Mayer, B.; Assisi, L.; Botte, V.; Cecio, A. 1999: NADPH-diaphorase and NOS enzymatic activities in some neurons of reptilian gut and their relationships with two neuropeptides. Anatomy and Embryology 199(5): 397-405
Sbarbati, A.; Crescimanno, C.; De Rossi, V.; Bernardi, P.; Osculati, F. 1999: NADPH-diaphorase and NOS-1 positive ganglion cells are found in the rat vallate papilla/von Ebner gland complex. Histochemical Journal 31(7): 417-424
Munekawa, N.; Sugiyo, S.; Varathan, V.; Fukami, H.; Wakisaka, S.; Shigenaga, Y.; Takemura, M. 2002: NADPH-diaphorase and calcium binding proteins in the trigeminal nucleus oralis of rats. Somatosensory and Motor Research 19(3): 173-180
Nakamura, H.; Itoh, K.; Kawabuchi, M. 1999: NADPH-diaphorase and cytosolic urea cycle enzymes in the rat accessory olfactory bulb. Journal of Chemical Neuroanatomy 17(2): 109-117
Vasilaki, A.; Gardette, R.; Epelbaum, J.; Thermos, K. 2001: NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Investigative Ophthalmology and Visual Science 42(7): 1600-1609
Sabbatini, M.; Bronzetti, E.; Felici, L.; Fringuelli, C.; Sagratella, S.; Amenta, F. 1999: NADPH-diaphorase histochemistry in the rat cerebral cortex and hippocampus: Effect of electrolytic lesions of the nucleus basalis magnocellularis. Mechanisms of Ageing and Development 107(2): 147-157
Schuppe, H.; Aonuma, H.; Newland, P.L. 2001: NADPH-diaphorase histochemistry in the terminal abdominal ganglion of the crayfish. Cell and Tissue Research 303(2): 289-299
Morris, J.C.; Phelps, P.E.; Simmons, D.D. 1999: NADPH-diaphorase histochemistry reveals an autonomic-like innervation in the postnatal hamster cochlea. Journal of Comparative Neurology 412(3): 458-468
Wilhelm, M.; Bátori, Z.; Pásztor, I.; Gábriel, R. 1998: NADPH-diaphorase positive myenteric neurons in the ileum of guinea-pig, rat, rabbit and cat: a comparative study. European Journal of Morphology 36(3): 143-152
Foster, J.A.; Phelps, P.E. 2000: NADPH-diaphorase reveals presumptive sympathetic primary afferents in the developing human spinal cord. Autonomic Neuroscience: Basic and Clinical 84(1-2): 111-117
Johannes, S.; Reif, A.; Senitz, D.; Riederer, P.; Lauer, M. 2003: NADPH-diaphorase staining reveals new types of interneurons in human putamen. Brain Research 980(1): 92-99
Lázár, G.; Losonczy, A. 1999: NADPH-diaphorase-positive neurons and pathways in the brain of the frog Rana esculenta. Anatomy and Embryology 199(2): 185-198
Ouda, L.; Nwabueze-Ogbo, F.C.; Druga, R.; Syka, J. 2003: NADPH-diaphorase-positive neurons in the auditory cortex of young and old rats. Neuroreport 14(3): 363-366
Briñón, J.G.; Crespo, C.; Weruaga, E.; Alonso, J.; Sobreviela, T.; Aijón, J.; Alonso, J.R. 1998: NADPH-diaphorase/nitric oxide synthase-positive elements in the human olfactory bulb. Neuroreport 9(14): 3141-3146
Bylund, J.; Samuelsson, M.; Collins, L.Vincent.; Karlsson, A. 2003: NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Experimental Cell Research 282(2): 70-77
Aramaki, Y.; Yotsumoto, S.; Watanabe, H.; Tsuchiya, S. 2002: NADPH-oxidase may contribute to IL-12 production in macrophages stimulated with CpG phosphorothioate oligodeoxynucleotides. Biological and Pharmaceutical Bulletin 25(3): 351-355
Okamura, T.; Kurisu, K.; Yamamoto, W.; Takano, H.; Nishiyama, M. 2000: NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. International Journal of Oncology 16(2): 295-303
Heyes, D.J.; Martin, G.E.; Reid, R.J.; Hunter, C.N.; Wilks, H.M. 2000: NADPH:protochlorophyllide oxidoreductase from Synechocystis: Overexpression, purification and preliminary characterisation. FEBS Letters 483(1): 47-51
Marrero, J.A.; Fontana, R.J.; Su, G.L.; Conjeevaram, H.S.; Emick, D.M.; Lok, A.S. 2002: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36(6): 1349-1354
Madsen, A.M. 2003: NAGase activity in airborne biomass dust and relationship between NAGase concentrations and fungal spores. Aerobiologia 19(2): 97-105
Sánchez-Pulido, L.; Yuan, Y.P.; Andrade, M.A.; Bork, P. 2000: NAIL-Network Analysis Interface for Linking HMMER results. Bioinformatics 16(7): 656-657
Mercer, E.A.; Korhonen, L.; Skoglösa, Y.; Olsson, P.A.; Kukkonen, J.P.; Lindholm, D. 2000: NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways. EMBO Journal 19(14): 3597-3607
Crocker, S.J.; Wigle, N.; Liston, P.; Thompson, C.S.; Lee, C.J.; Xu, D.; Roy, S.; Nicholson, D.W.; Park, D.S.; Mackenzie, A.; Korneluk, R.G.; Robertson, G.S. 2001: NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease. European Journal of Neuroscience 14(2): 391-400
Notarbartolo, M.; Cervello, M.; Dusonchet, L.; D'Alessandro, N. 2002: NAIP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukemia cells. Leukemia Research 26(9): 857-862
Lunetta, R.S.; Alvarez, R.; Edmonds, C.M.; Lyon, J.G.; Elvidge, C.D.; Bonifaz, R.; Garcia, C. 2002: NALC/Mexico land-cover mapping results: Implications for assessing landscape condition. International Journal of Remote Sensing 23(16): 3129-3148, 20 August
Debidda, M.; Sanna, B.; Cossu, A.; Posadino, A.M.; Tadolini, B.; Ventura, C.; Pintus, G. 2003: NAMI-A inhibits the PMA-induced ODC gene expression in ECV304 cells: involvement of PKC/Raf/Mek/ERK signalling pathway. International Journal of Oncology 23(2): 477-482
Knight, G.E.; Burnstock, G. 1999: NANC relaxation of the circular smooth muscle of the oesophagus of the Agama lizard involves the L-arginine-nitric oxide synthase pathway. Comparative Biochemistry and Physiology. Part C Pharmacology Toxicology and Endocrinology 122(2): 165-171
Bennett, M.R. 2000: NANC transmission at a varicosity: The individuality of single synapses. Journal of the Autonomic Nervous System 81(1-3): 25-30
Gozes, I.; Alcalay, R.; Giladi, E.; Pinhasov, A.; Furman, S.; Brenneman, D.E. 2002: NAP accelerates the performance of normal rats in the water maze. Journal of Molecular Neuroscience: Mn 19(1-2): 167-170
Leker, R.R.; Teichner, A.; Grigoriadis, N.; Ovadia, H.; Brenneman, D.E.; Fridkin, M.; Giladi, E.; Romano, J.; Gozes, I. 2002: NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33(4): 1085-1092
Wise, W.R. 1999: NAPL characterization via partitioning tracer tests: Quantifying effects of partitioning nonlinearities. Journal of Contaminant Hydrology 36(1-2): 167-183
Nambi, I.M.; Powers, S.E. 2000: NAPL dissolution in heterogeneous systems: An experimental investigation in a simple heterogeneous system. Journal of Contaminant Hydrology 44(2): 161-184
Gavva, N.R.; Wen, S.-C.; Daftari, P.; Moniwa, M.; Yang, W.-M.; Yang-Feng, L.-P.T.; Seto, E.; Davie, J.R.; Shen, C.-K.J. 2002: NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor. Genomics 79(3): 423-431
Scanlon, M.J. 2000: NARROW SHEATH1 functions from two meristematic foci during founder-cell recruitment in maize leaf development. Development 127(21): 4573-4585
Russell, A.; Dennis, R. 2000: NARSTO critical review of photochemical models and modeling. Atmospheric Environment 34(12-14): 2283-2324
Hales, J.M. 2003: NARSTO fine-particle and ozone assessments. Environmental Pollution 123(3): 393-397
Wen, J.; Krishan, A.; Thomas, R.A. 2001: NASA/American Cancer Society High-Resolution Flow Cytometry Project - II. Effect of pH and DAPI concentration on dual parametric analysis of DNA/DAPI fluorescence and electronic nuclear volume. Cytometry 43(1): 12-15
Krishan, A.; Wen, J.; Thomas, R.A.; Sridhar, K.S.; Smith, W.I.Jr 2001: NASA/American Cancer Society High-Resolution Flow Cytometry Project - III. Multiparametric analysis of DNA content and electronic nuclear volume in human solid tumors. Cytometry 43(1): 16-22
Thomas, R.A.; Krishan, A.; Robinson, D.M.; Sams, C.; Costa, F. 2001: NASA/American Cancer Society High-Resolution Flow Cytometry Project-I. Cytometry 43(1): 2-11
Gilbert, B.K.; Mitchell, M.P.; Bengali, A.R.; Khandheria, B.K. 1999: NASA/DARPA advanced communications technology satellite project for evaluation of telemedicine outreach using next-generation communications satellite technology: Mayo Foundation participation. Mayo Clinic Proceedings 74(8): 753-757
Chitturi, S.; Abeygunasekera, S.; Farrell, G.C.; Holmes-Walker, J.; Hui, J.M.; Fung, C.; Karim, R.; Lin, R.; Samarasinghe, D.; Liddle, C.; Weltman, M.; George, J. 2002: NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35(2): 373-379
Blechacz, B.; Stremmel, W. 2003: NASH: Nichtalkoholische Steatohepatitis. Zeitschrift fuer Gastroenterologie 41(1): 77-90
Maquat, L.E. 2002: NASty effects on fibrillin pre-mRNA splicing: another case of ESE does it, but proposals for translation-dependent splice site choice live on. Genes and Development 16(14): 1743-1753
Roth, W.K.; Buhr, S.; Drosten, C.; Seifried, E. 2000: NAT and viral safety in blood transfusion. Vox Sanguinis 78(Suppl): 257-259
Roth, W.Kurt.; Weber, M.; Petersen, D.; Drosten, C.; Buhr, S.; Sireis, W.; Weichert, W.; Hedges, D.; Seifried, E. 2002: NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42(7): 869-875
Millikan, R.C. 2000: NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 9(2): 217-219
Rollinson, S.; Roddam, P.; Willett, E.; Roman, E.; Cartwright, R.; Jack, A.; Morgan, G.J. 2001: NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 10(5): 567-568
Nyéki, A.; Buclin, T.; Biollaz, J.; Decosterd, L.A. 2003: NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios. British Journal of Clinical Pharmacology 55(1): 62-67
Hegele, R.A.; Kwan, K.; Harris, S.B.; Hanley, A.J.; Zinman, B.; Cao, H. 2000: NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree. Pharmacogenetics 10(3): 233-238
van der Hel, O.L.; Peeters, P.H.M.; Hein, D.W.; Doll, M.A.; Grobbee, D.E.; Kromhout, D.; Bueno de Mesquita, H.Bas. 2003: NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13(7): 399-407
Marcus, P.M.; Vineis, P.; Rothman, N. 2000: NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10(2): 115-122
Meyer, D.; Parkin, D.P.; Seifart, H.I.; Maritz, J.Stefan.; Engelbrecht, A.H.; Werely, C.J.; van Helden, P.D. 2003: NAT2 slow acetylator function as a risk indicator for age-related cataract formation. Pharmacogenetics 13(5): 285-289
Seow, A.; Zhao, B.; Poh, W.T.; Teh, M.; Eng, P.; Wang, Y.T.; Tan, W.C.; Lee, E.J.; Lee, H.P. 1999: NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. Carcinogenesis 20(9): 1877-1881
Slattery, M.L.; Potter, J.D.; Samowitz, W.; Bigler, J.; Caan, B.; Leppert, M. 1998: NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 7(12): 1079-1084
Barbara, J.A. 1999: NAT: perspectives for cellular components. Biologicals: Journal of the International Association of Biological Standardization 27(4): 333-336
Anonymous 2001: NATO Advanced Research Workshop on Endocrine Disrupters and Carcinogenic Risk Assessment, Bialystok, Poland, May 8-12, 2001. Folia Histochemica et Cytobiologica 39(Suppl 1): 7-83
Ren, J.; Bailly, C.; Chaires, J.B. 2000: NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA. FEBS Letters 470(3): 355-359
Mei, H.; Yu, C.; Chan, K.K. 1999: NB1-C16-insulin: site-specific synthesis, purification, and biological activity. Pharmaceutical Research 16(11): 1680-1686
Dellinger, R.W.; Karjian, P.L.; Neuteboom, S.T.C. 2003: NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint. Anti-Cancer Drugs 14(6): 449-455
Li, Q.; Lee, J.Y.; Castillo, R.; Hixon, M.S.; Pujol, C.; Doppalapudi, V.R.; Shepard, H.M.; Wahl, G.M.; Lobl, T.J.; Chan, M.F. 2002: NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. Antimicrobial Agents and ChemoTherapy 46(5): 1262-1268
Zhang-Hao [author, Reprint-Author]; Zeng-Xianchang [author, Reprint-Author]; Zhang-Kejian [author, Reprint-Author]; Et-Al 2002: NB4 cell differentiation induced by cinnamic acid and expressions of c-myc and c-fos. Wuhan Daxue Xuebao (Yixue Ban) 23(4): 319-321
Raih, M.F.; Harmin, S.A.; Ahmad, H.A.; Isa, M.N. Mat; Mahadi, N.M.; Ibrahim, A.L.; Mohamed, R. 2003: NBBnet: The National Biotechnology and Bioinformatics network: A Malaysian initiative towards a national infrastructure for bioinformatics. Electronic Journal of Biotechnology 6(1): 8-12
Pushkin, A.; Yip, K.P.; Clark, I.; Abuladze, N.; Kwon, T.H.; Tsuruoka, S.; Schwartz, G.J.; Nielsen, S.; Kurtz, I. 1999: NBC3 expression in rabbit collecting duct: colocalization with vacuolar H+-ATPase. American Journal of Physiology 277(6): F974-F981
Bednarczyk, D.; Mash, E.A.; Aavula, B.R.; Wright, S.H. 2000: NBD-TMA: A novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules. Pflugers Archiv: European Journal of Physiology 440(1): 184-192
Hanson, P.K.; Grant, A.M.; Nichols, J.W. 2002: NBD-labeled phosphatidylcholine enters the yeast vacuole via the pre-vacuolar compartment. Journal of Cell Science 115(Part 13): 2725-2733
Crowe, P.D.; Qin, Y.; Conlon, P.J.; Antel, J.P. 2000: NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients. Annals of Neurology 48(5): 758-765
Dumontier, M.; Hogue, C.W.V. 2002: NBLAST: A cluster variant of BLAST for NXN comparisons. Bmc Bioinformatics 3: 13
Ingraham, C.A.; Rising, L.J. 2000: NBN defined medium supports the development of O4+/O1- immunopanned pro-oligodendroglia. Developmental Brain Research 125(1-2): 1-8, 29 December
Zeng, X.; Zhu, Y.; Lu, H. 2001: NBP is the p53 homolog p63. Carcinogenesis 22(2): 215-219
Shirakawa, H.; Landsman, D.; Postnikov, Y.V.; Bustin, M. 2000: NBP-45, a novel nucleosomal binding protein with a tissue-specific and developmentally regulated expression. Journal of Biological Chemistry 275(9): 6368-6374
Shimizu, Y.; Akashi, T.; Okuda, A.; Kikuchi, A.; Fukui, K. 2000: NBP1 (Nap1 Binding Protein 1), an essential gene for G2/M transition of Saccharomyces cerevisiae, encodes a protein of distinct sub-nuclear localization. Gene 246(1-2): 395-404
Zhang, J.; Peng, X.; Wei, G.; Su, D. 1999: NBPA: A cerebral ischaemic protective agent. Clinical and Experimental Pharmacology and Physiology 26(10): 845-846
Follett, P.L.; Rosenberg, P.A.; Volpe, J.J.; Jensen, F.E. 2000: NBQX attenuates excitotoxic injury in developing white matter. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(24): 9235-9241
Mu, X.; Azbill, R.D.; Springer, J.E. 2002: NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury. Journal of Neurotrauma 19(8): 917-927
Whitehouse, C.; Chambers, J.; Howe, K.; Cobourne, M.; Sharpe, P.; Solomon, E. 2002: NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube. European Journal of Biochemistry 269(2): 538-545
Uzagare, M.C.; Padiya, K.J.; Salunkhe, M.M.; Sanghvi, Y.S. 2003: NBS-DMSO as a nonaqueous nonbasic oxidation reagent for the synthesis of oligonucleotides. Bioorganic and Medicinal Chemistry Letters 13(20): 3537-3540
Wu, G.; Lee, W.H.; Chen, P.L. 2000: NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. Journal of Biological Chemistry 275(39): 30618-30622
Kobayashi, J.; Tauchi, H.; Sakamoto, S.; Nakamura, A.; Morishima, K-ichi.; Matsuura, S.; Kobayashi, T.; Tamai, K.; Tanimoto, K.; Komatsu, K. 2002: NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Current Biology: Cb 12(21): 1846-1851
Lesueur, F.; Mesnil, M.; Delouvée, A.; Girault, J.M.; Yamasaki, H.; Thiery, J.P.; Jouanneau, J. 2002: NBT-II carcinoma behaviour is not dependent on cell-cell communication through gap junctions. Biochemical and Biophysical Research Communications 294(1): 108-115
Okamoto, T.; Kobayashi, T.; Jeong, S.Y. 2001: NC-1500 prevents concanavalin A-induced mice hepatitis without affecting cytokine gene expression. International Journal of Molecular Medicine 8(2): 181-182
Suto, H.; Matsuda, H.; Mitsuishi, K.; Hira, K.; Uchida, T.; Unno, T.; Ogawa, H.; Ra, C. 1999: NC/Nga mice: a mouse model for atopic dermatitis. International Archives of Allergy and Immunology 120(Suppl): 70-75
Xu, R.; Yao, Z.Y.; Xin, L.; Zhang, Q.; Li, T.P.; Gan, R.B. 2001: NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochemical and Biophysical Research Communications 289(1): 264-268
Binder, T.; Assayag, P.; Baer, F.; Flachskampf, F.; Kamp, O.; Nienaber, C.; Nihoyannopoulos, P.; Piérard, L.; Steg, G.; Vanoverschelde, J.L.; Van der Wouw, P.; Meland, N.; Marelli, C.; Lindvall, K. 1999: NC100100, a new echo contrast agent for the assessment of myocardial perfusion--safety and comparison with technetium-99m sestamibi single-photon emission computed tomography in a randomized multicenter study. Clinical Cardiology 22(4): 273-282
Lantuéjoul, S.; Laverrière, M.H.; Sturm, N.; Moro, D.; Frey, G.; Brambilla, C.; Brambilla, E. 2000: NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. Human Pathology 31(4): 415-421
Ryan, T.A. 2001: NCAM and vesicle cycling: The importance of good glue in the long run. Neuron 32(5): 759-761
Prag, S.ør.; Lepekhin, E.A.; Kolkova, K.; Hartmann-Petersen, R.; Kawa, A.; Walmod, P.S.; Belman, V.; Gallagher, H.C.; Berezin, V.; Bock, E.; Pedersen, N. 2002: NCAM regulates cell motility. Journal of Cell Science 115(Part 2): 283-292
Schmid, R.S.; Graff, R.D.; Schaller, M.D.; Chen, S.; Schachner, M.; Hemperly, J.J.; Maness, P.F. 1999: NCAM stimulates the ras-MAPK pathway and CREB phosphorylation in neuronal cells. Journal of Neurobiology 38(4): 542-558
Gattenlöhner, S.; Waller, C.; Ertl, G.; Bültmann, B.-D.; Müller-Hermelink, H.-K.; Marx, A. 2003: NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. American Journal of Pathology 163(3): 1081-1090
Winter, A.; Bornemann, A. 1999: NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases. Neuropathology and Applied Neurobiology 25(5): 417-424
Pruitt, K.D.; Tatusova, T.; Maglott, D.R. 2003: NCBI Reference Sequence project: update and current status. Nucleic Acids Research 31(1): 34-37
Highsmith, S.; Thoene, M.; Sablin, E.; Polosukhina, K. 2001: NCD activation of tubulin polymerization. Biophysical Chemistry 92(1-2): 127-139
Alexander, C.M.; Landsman, P.B.; Teutsch, S.M.; Haffner, S.M. 2003: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52(5): 1210-1214
Stoletov, K.V.; Ratcliffe, K.E.; Spring, S.C.; Terman, B.I. 2001: NCK and PAK participate in the signaling pathway by which vascular endothelial growth factor stimulates the assembly of focal adhesions. Journal of Biological Chemistry 276(25): 22748-22755
Ouznadji, H.; Wissocq, J.C.; Martini, F.; Ouznadji, S.; Thellier, M. 2000: NCR: Technical aspects and application to lithium mapping in mouse embryos. Journal of Trace and Microprobe Techniques 18(1): 143-152
Mora, S.; Durham, P.L.; Smith, J.R.; Russo, A.F.; Jeromin, A.; Pessin, J.E. 2002: NCS-1 inhibits insulin-stimulated GLUT4 translocation in 3T3L1 adipocytes through a phosphatidylinositol 4-kinase-dependent pathway. Journal of Biological Chemistry 277(30): 27494-27500
Tesei, A.; Ricotti, L.; Ulivi, P.; Medri, L.; Amadori, D.; Zoli, W. 2003: NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines. International Journal of Oncology 22(6): 1297-1302
Fiorucci, S.; Mencarelli, A.; Meneguzzi, A.; Lechi, A.; Morelli, A.; del Soldato, P.; Minuz, P. 2002: NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation 106(24): 3120-3125
Fiorucci, S.; Mencarelli, A.; Mannucci, R.; Distrutti, E.; Morelli, A.; del Soldato, P.; Moncada, S. 2002: NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB Journal 16(12): 1645-1647
Van Eylen, F.; Bollen, A.; Herchuelz, A. 2001: NCX1 Na/Ca exchanger splice variants in pancreatic islet cells. Journal of Endocrinology 168(3): 517-526
Babu, M.Madan. 2003: NCI: A server to identify non-canonical interactions in protein structures. Nucleic Acids Research 31(13): 3345-3348
Kuramitsu, Y.; Hamada, J.; Tsuruoka, T.; Morikawa, K.; Naito, S.; Kobayashi, H.; Hosokawa, M. 1998: ND-2001 suppresses lung metastasis of human renal cancer cells in athymic mice. Anti-Cancer Drugs 9(8): 739-741
Burkham, J.; Coen, D.M.; Weller, S.K. 1998: ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. Journal of Virology 72(12): 10100-10107
Loy, C.J.; Lydall, D.; Surana, U. 1999: NDD1, a high-dosage suppressor of cdc28-1N, is essential for expression of a subset of late-S-phase-specific genes in Saccharomyces cerevisiae. Molecular and Cellular Biology 19(5): 3312-3327
Najm, I.; Trussell, R.R.odes 2001: NDMA formation in water and wastewater. Journal - American Water Works Association 93(2): 92-99
Kommineni, S.; Ela, W.P.; Arnold, R.G.; Huling, S.G.; Hester, B.J.; Betterton, E.A. 2003: NDMA treatment by sequential GAC adsorption and Fenton-driven destruction. Environmental Engineering Science 20(4): 361-373
Kreimeyer, A.; Schneider, B.; Sarfati, R.; Faraj, A.; Sommadossi, J.P.; Veron, M.; Deville-Bonne, D. 2001: NDP kinase reactivity towards 3TC nucleotides. Antiviral Research 50(2): 147-156
Goulard, F.; Le-Corre, G.; Diouris, M.; Deslandes, E.; Floc'h, J.-Yves 2001: NDP-sugars, floridoside and floridean starch levels in relation to activities of UDP-glucose pyrophosphorylase and UDP-glucose-4-epimerase in Solieria chordalis (Rhodophyceae) under experimental conditions. Phycological Research 49(1): 43-50
Zhang, H.; Fu, W. 2002: NDPP1 is a novel CARD domain containing protein which can inhibit apoptosis and suppress NF-kappaB activation. International Journal of Oncology 20(5): 1035-1040
Hanada, N.; Makino, K.; Koga, H.; Morisaki, T.; Kuwahara, H.; Masuko, N.; Tabira, Y.; Hiraoka, T.; Kitamura, N.; Kikuchi, A.; Saya, H. 2000: NE-dlg, a mammalian homolog of Drosophila dlg tumor suppressor, induces growth suppression and impairment of cell adhesion: possible involvement of down-regulation of beta-catenin by NE-dlg expression. International Journal of Cancer 86(4): 480-488
Vincze, T.; Posfai, J.; Roberts, R.J. 2003: NEBcutter: A program to cleave DNA with restriction enzymes. Nucleic Acids Research 31(13): 3688-3691
Badowicz, B. 2000: NEC - Obumierajace zapalenie jelit noworodka: Sposob postepowania i wyniki leczenia: Analiza porownawcza materialu Szkockiego (Glasgow) i Polskiego (Pomorze Zachodnie). Roczniki Pomorskiej Akademii Medycznej w Szczecinie 46: 137-149
Sugita, S.; Ho, A.; Südhof, T.C. 2002: NECABs: a family of neuronal Ca(2+)-binding proteins with an unusual domain structure and a restricted expression pattern. Neuroscience 112(1): 51-63
Asanoma, K.; Matsuda, T.; Kondo, H.; Kato, K.; Kishino, T.; Niikawa, N.; Wake, N.; Kato, H. 2003: NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics 81(1): 15-25
Twery, M.J.; Rauscher, H.M.; Bennett, D.J.; Thomasma, S.A.; Stout, S.L.; Palmer, J.F.; Hoffman, R.E.; Decalesta, D.S.; Gustafson, E.; Cleveland, H.; Grove, J.M.; Nute, D.; Kim, G.; Kollasch, R.P. 2000: NED-1: Integrated analyses for forest stewardship decisions. Computers and Electronics in Agriculture 27(1-3): 167-193
Liu, J.; Furukawa, M.; Matsumoto, T.; Xiong, Y. 2002: NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Molecular Cell 10(6): 1511-1518
Dil Kuazi, A.; Kito, K.; Abe, Y.; Shin, R.-W.; Kamitani, T.; Ueda, N. 2003: NEDD8 protein is involved in ubiquitinated inclusion bodies. Journal of Pathology 199(2): 259-266
Kawakami, T.; Chiba, T.; Suzuki, T.; Iwai, K.; Yamanaka, K.; Minato, N.; Suzuki, H.; Shimbara, N.; Hidaka, Y.; Osaka, F.; Omata, M.; Tanaka, K. 2001: NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO Journal 20(15): 4003-4012
Mendoza, H.M.; Shen, L.-N.; Botting, C.; Lewis, A.; Chen, J.; Ink, B.; Hay, R.T. 2003: NEDP1, a highly conserved cysteine protease that de NEDDylates Cullins. Journal of Biological Chemistry 278(28): 25637-25643
Liti, G.; Louis, E.J. 2003: NEJ1 prevents NHEJ-dependent telomere fusions in yeast without telomerase. Molecular Cell 11(5): 1373-1378
Matsuo, M.; Tucker, S.J.; Ashcroft, F.M.; Amachi, T.; Ueda, K. 1999: NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1. FEBS Letters 458(3): 292-294
Agou, F.; Ye, F.; Goffinont, S.ép.; Courtois, G.; Yamaoka, S.; Israël, A.; Véron, M. 2002: NEMO trimerizes through its coiled-coil C-terminal domain. Journal of Biological Chemistry 277(20): 17464-17475
Petersen, T.; Papakostas, G.I.; Bottonari, K.; Iacoviello, B.; Alpert, J.E.; Fava, M.; Nierenberg, A.A. 2002: NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Research 109(1): 9-16
Hemond, H.; Camilli, R. 2002: NEREUS: Engineering concept for an underwater mass spectrometer. Trends in Analytical Chemistry 21(8): 526-533
Christensen, R.A.; Fujikawa, K.; Madore, R.; Oettgen, P.; Varticovski, L. 2002: NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia. Journal of Cellular Biochemistry 85(3): 505-515
Nakano, K.; Yamauchi, J.; Nakagawa, K.; Itoh, H.; Kitamura, N. 2000: NESK, a member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and is expressed during the late stages of embryogenesis. Journal of Biological Chemistry 275(27): 20533-20539
La Cour, T.; Gupta, R.; Rapacki, K.; Skriver, K.; Poulsen, F.M.; Brunak, S.ør. 2003: NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Research 31(1): 393-396
Koltovaya, N.A.; Guerasimova, A.S.; Tchekhouta, I.A.; Devin, A.B. 2003: NET1 and HFI1 genes of yeast mediate both chromosome maintenance and mitochondrial rho(-) mutagenesis. Yeast 20(11): 955-971
Ahmad, S.; Gromiha, M.Michael. 2002: NETASA: neural network based prediction of solvent accessibility. Bioinformatics 18(6): 819-824
Cinek, O.; Drevínek, P.; Sumník, Zĕk.; Bendlová, Bĕla.; Sedláková, Pína.; Kolousková, S.; Snajderová, M.; Vavrinec, J. 2003: NEUROD polymorphism Ala45Thr is associated with Type 1 diabetes mellitus in Czech children. Diabetes Research and Clinical Practice 60(1): 49-56
Willms, A.R. 2002: NEUROFIT: Software for fitting Hodgkin-Huxley models to voltage-clamp data. Journal of Neuroscience Methods 121(2): 139-150
Phan, I.Q.H.; Pilbout, S.F.; Fleischmann, W.; Bairoch, A. 2003: NEWT, a new taxonomy portal. Nucleic Acids Research 31(13): 3822-3823
Mulford, L.A.; Taylor, J.S.; Nickerson, D.M.; Chen, S.S.ing 1999: NF performance at full and pilot scale. Journal - American Water Works Association 91(6): 64-75
Lin, C.J.; Martens, J.W.; Miller, W.L. 2001: NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells. Molecular Endocrinology 15(8): 1277-1293
Kondo, E.; Harashima, A.; Takabatake, T.; Takahashi, H.; Matsuo, Y.; Yoshino, T.; Orita, K.; Akagi, T. 2003: NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor. European Journal of Immunology 33(1): 1-11
Lee, J.-M.; Shih, A.Y.; Murphy, T.H.; Johnson, J.A. 2003: NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex i inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. Journal of Biological Chemistry 278(39): 37948-37956
Yang, Z.; Wara-Aswapati, N.; Chen, C.; Tsukada, J.; Auron, P.E. 2000: NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. Journal of Biological Chemistry 275(28): 21272-21277
Xie, Y.; Chen, C.; Stevenson, M.A.; Hume, D.A.; Auron, P.E.; Calderwood, S.K. 2002: NF-IL6 and HSF1 have mutually antagonistic effects on transcription in monocytic cells. Biochemical and Biophysical Research Communications 291(4): 1071-1080
Zhong, Z.D.; Hammani, K.; Bae, W.S.; DeClerck, Y.A. 2000: NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2. Journal of Biological Chemistry 275(24): 18602-18610
Shi, Q.; Gross, K.W.; Sigmund, C.D. 2001: NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension 38(3): 332-336
Caretti, G.; Motta, M.C.; Mantovani, R. 1999: NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Molecular and Cellular Biology 19(12): 8591-8603
Dugast, C.; Weber, M.J. 2001: NF-Y binding is required for transactivation of neuronal aromatic L-amino acid decarboxylase gene promoter by the POU-domain protein Brn-2. Brain Research. Molecular Brain Research 89(1-2): 58-70
Liberati, C.; di Silvio, A.; Ottolenghi, S.; Mantovani, R. 1999: NF-Y binding to twin CCAAT boxes: role of Q-rich domains and histone fold helices. Journal of Molecular Biology 285(4): 1441-1455
Zhu, J.; Giannola, D.M.; Zhang, Y.; Rivera, A.J.; Emerson, S.G. 2003: NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4. Blood 102(7): 2420-2427
Zemzoumi, K.; Frontini, M.; Bellorini, M.; Mantovani, R. 1999: NF-Y histone fold alpha1 helices help impart CCAAT specificity. Journal of Molecular Biology 286(2): 327-337
Teran-Garcia, M.; Rufo, C.; Nakamura, M.T.; Osborne, T.F.; Clarke, S.D. 2002: NF-Y involvement in the polyunsaturated fat inhibition of fatty acid synthase gene transcription. Biochemical and Biophysical Research Communications 290(4): 1295-1299
Frontini, M.; Imbriano, C.; diSilvio, A.; Bell, B.; Bogni, A.; Romier, C.; Moras, D.; Tora, L.; Davidson, I.; Mantovani, R. 2002: NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s. Journal of Biological Chemistry 277(8): 5841-5848
Chang, Z.F.; Huang, D.Y.; Hu, S.F. 1999: NF-Y-mediated trans-activation of the human thymidine kinase promoter is closely linked to activation of cyclin-dependent kinase. Journal of Cellular Biochemistry 75(2): 300-309
Woon, S-T.; Zwain, S.; Schooltink, M.A.; Newth, A.L.; Baguley, B.C.; Ching, L-M. 2003: NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). European Journal of Cancer 39(8): 1176-1183
Wu, J.; Zern, M.A. 1999: NF-kappa B, liposomes and pathogenesis of hepatic injury and fibrosis. Frontiers in Bioscience: a Journal and Virtual Library 4: D520-D527
Mudipalli, A.; Li, Z.; Hromchak, R.; Bloch, A. 2001: NF-kappaB (p65/RelA) as a regulator of TNFalpha-mediated ML-1 cell differentiation. Leukemia 15(5): 808-813
Natarajan, M.; Vijayalaxmi; Szilagyi, M.; Roldan, F.N.; Meltz, M.L. 2002: NF-kappaB DNA-binding activity after high peak power pulsed microwave (8.2 GHz) exposure of normal human monocytes. Bioelectromagnetics 23(4): 271-277
Lee, B.-H.; Park, S.-Y.; Kang, K.-B.; Park, R.-W.; Kim, I.-S. 2002: NF-kappaB activates fibronectin gene expression in rat hepatocytes. Biochemical and Biophysical Research Communications 297(5): 1218-1224
Yamaza, T.; Masuda, K.F.; Tsukiyama, Y.; Nishijima, K.; Murakami, R.; Kido, M.A.; Koyano, K.; Tanaka, T. 2003: NF-kappaB activation and iNOS expression in the synovial membrane of rat temporomandibular joints after induced synovitis. Journal of Dental Research 82(3): 183-188
Li, L.; Rao, J.N.; Bass, B.L.; Wang, J.Y. 2001: NF-kappaB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 280(5): G992
Pomerantz, J.L.; Baltimore, D. 1999: NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO Journal 18(23): 6694-6704
Huang, T.T.; Wuerzberger-Davis, S.M.; Seufzer, B.J.; Shumway, S.D.; Kurama, T.; Boothman, D.A.; Miyamoto, S. 2000: NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. Journal of Biological Chemistry 275(13): 9501-9509
Zamanian-Daryoush, M.; Mogensen, T.H.; DiDonato, J.A.; Williams, B.R. 2000: NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Molecular and Cellular Biology 20(4): 1278-1290
Yun, C.; Um, H.Ryun.; Jin, Y.Hee.; Wang, J-Hee.; Lee, M-Ock.; Park, S.; Lee, J-Ho.; Cho, H. 2002: NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Letters 184(1): 97-104
Xia, Y.F.; Liu, L.P.; Zhong, C.P.; Geng, J.G. 2001: NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. Biochemical and Biophysical Research Communications 289(4): 851-856
Ichiyama, T.; Isumi, H.; Yoshitomi, T.; Nishikawa, M.; Matsubara, T.; Furukawa, S. 2002: NF-kappaB activation in cerebrospinal fluid cells from patients with meningitis. Neurological Research 24(7): 709-712
Wu, T.; Chen, Y.; Chiang, S.K.S.; Tso, M.O.M. 2002: NF-kappaB activation in light-induced retinal degeneration in a mouse model. IOVS Investigative Ophthalmology and Visual Science 43(9): 2834-2840
Chen, X.; Ji, B.; Han, B.; Ernst, S.A.; Simeone, D.; Logsdon, C.D. 2002: NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 122(2): 448-457
Ichiyama, T.; Yoshitomi, T.; Nishikawa, M.; Fujiwara, M.; Matsubara, T.; Hayashi, T.; Furukawa, S. 2001: NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clinical Immunology 99(3): 373-377
Hasegawa, K.; Ichiyama, T.; Isumi, H.; Nakata, M.; Sase, M.; Furukawa, S. 2003: NF-kappaB activation in peripheral blood mononuclear cells in neonatal asphyxia. Clinical and Experimental Immunology 132(2): 261-264
O'Neil, J.; Ventura, J.-J.; Cusson, N.; Kelliher, M. 2003: NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors. Blood 102(7): 2593-2596
Bours, V.; Bonizzi, G.; Bentires-Alj, M.; Bureau, F.; Piette, J.; Lekeux, P.; Merville, M. 2000: NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology 153(1-3): 27-38
Ward, C.; Chilvers, E.R.; Lawson, M.F.; Pryde, J.G.; Fujihara, S.; Farrow, S.N.; Haslett, C.; Rossi, A.G. 1999: NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. Journal of Biological Chemistry 274(7): 4309-4318
Jokelainen, K.; Reinke, L.A.; Nanji, A.A. 2001: Nf-kappab activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 16(1): 36-39
Rakonczay, Zán.; Jármay, K.; Kaszaki, József.; Mándi, Y.; Duda, Eö.; Hegyi, Péter.; Boros, I.; Lonovics, János.; Takács, Tás. 2003: NF-kappaB activation is detrimental in arginine-induced acute pancreatitis. Free Radical Biology and Medicine 34(6): 696-709
Zahradka, P.; Werner, J.P.; Buhay, S.; Litchie, B.; Helwer, G.; Thomas, S. 2002: NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. Journal of Molecular and Cellular Cardiology 34(12): 1609-1621
Ichiyama, T.; Okada, K.; Campbell, I.L.; Furukawa, S.; Lipton, J.M. 2000: NF-kappaB activation is inhibited in human pulmonary epithelial cells transfected with alpha-melanocyte-stimulating hormone vector. Peptides 21(10): 1473-1477
Cafferata, E.G.; Guerrico, A.M.; Pivetta, O.H.; Santa-Coloma, T.A. 2001: NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta. Journal of Biological Chemistry 276(18): 15441-15444
Kim, J.Y.; Lee, S.; Hwangbo, B.; Lee, C.T.; Kim, Y.W.; Han, S.K.; Shim, Y.S.; Yoo, C.G. 2000: NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis. Biochemical and Biophysical Research Communications 273(1): 140-146
Hsu, M.H.; Wang, M.; Browning, D.D.; Mukaida, N.; Ye, R.D. 1999: NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood 93(10): 3241-3249
Zen, K.; Karsan, A.; Stempien-Otero, A.; Yee, E.; Tupper, J.; Li, X.; Eunson, T.; Kay, M.A.; Wilson, C.B.; Winn, R.K.; Harlan, J.M. 1999: NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. Journal of Biological Chemistry 274(40): 28808-28815
Paludan, S.R.; Ellermann-Eriksen, S.; Mogensen, S.C. 1998: NF-kappaB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-gamma-induced nitric oxide production in macrophages. Journal of General Virology 79: 2785-2793
Elgavish, A. 2000: NF-kappaB activation mediates the response of a subpopulation of basal uroepithelial cells to a cell wall component of Enterococcus faecalis. Journal of Cellular Physiology 182(2): 232-238
Cataldi, A.; Rapino, M.; Centurione, L.; Sabatini, N.; Grifone, G.; Garaci, F.; Rana, R. 2003: NF-kappaB activation plays an antiapoptotic role in human leukemic K562 cells exposed to ionizing radiation. Journal of Cellular Biochemistry 89(5): 956-963
Miagkov, A.V.; Kovalenko, D.V.; Brown, C.E.; Didsbury, J.R.; Cogswell, J.P.; Stimpson, S.A.; Baldwin, A.S.; Makarov, S.S. 1998: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proceedings of the National Academy of Sciences of the United States of America 95(23): 13859-13864
Javelaud, D.; Besancon, F. 2001: NF-kappaB activation results in rapid inactivation of JNK in TNFalpha-treated Ewing sarcoma cells: A mechanism for the anti-apoptotic effect of NF-kappaB. Oncogene 20(32): 4365-4372, 19 July
Nomura, F.; Kawai, T.; Nakanishi, K.; Akira, S. 2000: NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 5(3): 191-202
Bossis, G.; Salinas, S.; Cartier, C.; Devaux, C.; Briant, L. 2002: NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases. Febs Letters 516(1-3): 257-264
Kanamori, M.; Kai, C.; Hayashizaki, Y.; Suzuki, H. 2002: NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. Febs Letters 532(1-2): 241-246
Toliver-Kinsky, T.; Rassin, D.; Perez-Polo, J.Regino. 2002: NF-kappaB activity decreases in basal forebrain of young and aged rats after hyperoxia. Neurobiology of Aging 23(5): 899-905
Krushel, L.A.; Cunningham, B.A.; Edelman, G.M.; Crossin, K.L. 1999: NF-kappaB activity is induced by neural cell adhesion molecule binding to neurons and astrocytes. Journal of Biological Chemistry 274(4): 2432-2439
Von Knethen, A.; Callsen, D.; Brüne, B. 1999: NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Molecular Biology of the Cell 10(2): 361-372
Beetz, A.; Peter, R.U.; Oppel, T.; Kaffenberger, W.; Rupec, R.A.; Meyer, M.; van Beuningen, D.; Kind, P.; Messer, G. 2000: NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. International Journal of Radiation Biology 76(11): 1443-1453
Kim, J-Ouk.; Kim, H.Won.; Baek, K-Min.; Kang, C-Yuil. 2003: NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. Febs Letters 541(1-3): 163-170
Tantini, B.; Pignatti, C.; Fattori, M.; Flamigni, F.; Stefanelli, C.; Giordano, E.; Menegazzi, M.; Clô, C.; Caldarera, C.Marcello. 2002: NF-kappaB and ERK cooperate to stimulate DNA synthesis by inducing ornithine decarboxylase and nitric oxide synthase in cardiomyocytes treated with TNF and LPS. Febs Letters 512(1-3): 75-79
Sanz, O.; Acarin, L.; González, B.; Castellano, B. 2002: NF-kappaB and Ikappa Balpha expression following traumatic brain injury to the immature rat brain. Journal of Neuroscience Research 67(6): 772-780
Delfino, F.J.; Boustead, J.N.; Fix, C.; Walker, W.H. 2003: NF-kappaB and TNF-alpha stimulate androgen receptor expression in Sertoli cells. Molecular and Cellular Endocrinology 201(1-2): 1-12
Kim, H.; Seo, J.Y.; Kim, K.H. 2000: NF-kappaB and cytokines in pancreatic acinar cells. Journal of Korean Medical Science 15(Suppl): S53-S54
Santoro, M.Gabriella.; Rossi, A.; Amici, C. 2003: NF-kappaB and virus infection: who controls whom. EMBO Journal 22(11): 2552-2560
Hishikawa, K.; Nakaki, T. 2002: NF-kappaB as a therapeutic target for cardiovascular disease. HeartDrug 2(6): 303-311
Orlowski, R.Z.; Baldwin, A.S. 2002: NF-kappaB as a therapeutic target in cancer. Trends in Molecular Medicine 8(8): 385-389
Makarov, S.S. 2000: NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Molecular Medicine Today 6(11): 441-448
Barboric, M.; Nissen, R.M.; Kanazawa, S.; Jabrane-Ferrat, N.; Peterlin, B.M. 2001: NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Molecular Cell 8(2): 327-337
Haddad, J.J.; Collett, A.; Land, S.C.; Olver, R.E.; Wilson, S.M. 2001: NF-kappaB blockade reduces the O2-evoked rise in Na+ conductance in fetal alveolar cells. Biochemical and Biophysical Research Communications 281(4): 987-992
Asin, S.; Bren, G.D.; Carmona, E.M.; Solan, N.J.; Paya, C.V. 2001: NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. Journal of Virology 75(23): 11408-11416
Guttridge, D.C.; Albanese, C.; Reuther, J.Y.; Pestell, R.G.; Baldwin, A.S. 1999: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Molecular and Cellular Biology 19(8): 5785-5799
Estrada-Bernal, A.; Mendoza-Milla, C.; Ventura-Gallegos, Jé.Luis.; López-Bojórquez, L.Nikolaia.; Miranda-Peralta, E.; Arechavaleta-Velasco, Fán.; Vadillo-Ortega, F.; Sánchez-Sánchez, L.; Zentella-Dehesa, A. 2003: NF-kappaB dependent activation of human endothelial cells treated with soluble products derived from human lymphomas. Cancer Letters 191(2): 239-248
Plümpe, J.; Malek, N.P.; Bock, C.T.; Rakemann, T.; Manns, M.P.; Trautwein, C. 2000: NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. American Journal of Physiology. Gastrointestinal and Liver Physiology 278(1): G173-G183
Seitz, C.S.; Freiberg, R.A.; Hinata, K.; Khavari, P.A. 2000: NF-kappaB determines localization and features of cell death in epidermis. Journal of Clinical Investigation 105(3): 253-260
Pawlowski, J., E.; Nesterov, A.; Scheinman, R., I.; Johnson, T., R.; Kraft, A., S. 2000: NF-kappaB does not modulate sensitivity of renal carcinoma cells to TNFalpha-related apoptosis-inducing ligand (TRAIL). Anticancer Research 20(6B): 4243-4256
Frazier-Jessen, M.R.; Thompson, C.D.; Brown, R.; Rawat, R.; Nordan, R.P.; Feldman, G.M. 2002: NF-kappaB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264.7. Febs Letters 513(2-3): 203-207
Adib-Conquy, M.; Adrie, C.; Moine, P.; Asehnoune, K.; Fitting, C.; Pinsky, M.R.; Dhainaut, J.F.; Cavaillon, J.M. 2000: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. American Journal of Respiratory and Critical Care Medicine 162(5): 1877-1883
Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. 1999: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Molecular and Cellular Biology 19(4): 2690-2698
Meffert, M.K.; Chang, J.M.; Wiltgen, B.J.; Fanselow, M.S.; Baltimore, D. 2003: NF-kappaB functions in synaptic signaling and behavior. Nature Neuroscience 6(10): 1072-1078
Barrett, T.Q.; Kristiansen, L.H.; Ovesen, T. 2003: NF-kappaB in cultivated middle ear epithelium. International Journal of Pediatric Otorhinolaryngology 67(8): 895-903
Mitamura, Y.; Harada, T.; Harada, C.; Ohtsuka, K.; Kotake, S.; Ohno, S.; Tanaka, K.; Takeuchi, S.; Wada, K. 2003: NF-kappaB in epiretinal membranes after human diabetic retinopathy. Diabetologia 46(5): 699-703
Kuang, P-Ping.; Berk, J.L.; Rishikof, D.C.; Foster, J.A.; Humphries, D.E.; Ricupero, D.A.; Goldstein, R.H. 2002: NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. American Journal of Physiology. Cell Physiology 283(1): C58-C65
Kreuz, S.; Siegmund, D.; Scheurich, P.; Wajant, H. 2001: NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Molecular and Cellular Biology 21(12): 3964-3973
Delfino, F.J.; Walker, W.H. 1999: NF-kappaB induces cAMP-response element-binding protein gene transcription in sertoli cells. Journal of Biological Chemistry 274(50): 35607-35613
Wang, C.Y.; Guttridge, D.C.; Mayo, M.W.; Baldwin, A.S. 1999: NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Molecular and Cellular Biology 19(9): 5923-5929
Ouellet, M.; Roy, J.; Barbeau, B.; Geleziunas, R.; Tremblay, M.J. 2003: NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement. Biochemistry 42(27): 8260-8271
Muller, D.N.; Dechend, R.; Mervaala, E.M.; Park, J.K.; Schmidt, F.; Fiebeler, A.; Theuer, J.; Breu, V.; Ganten, D.; Haller, H.; Luft, F.C. 2000: NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35(1 Part 2): 193-201
Potoka, D.A.; Upperman, J.S.; Nadler, E.P.; Wong, C.T.; Zhou, X.; Zhang, X.Ru.; Ford, H.R. 2002: NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis. Journal of Surgical Research 106(1): 7-14
Liu, H.; Lo, C.R.; Czaja, M.J. 2002: NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35(4): 772-778
Pozarowski, P.; Halicka, D.H.; Darzynkiewicz, Z. 2003: NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently apoptosis and cell necrosis: Difficulties in identification of dead cells in such cultures. Cytometry 54A(2): 118-124
Sakon, S.; Xue, X.; Takekawa, M.; Sasazuki, T.; Okazaki, T.; Kojima, Y.; Piao, J-Hu.; Yagita, H.; Okumura, K.; Doi, T.; Nakano, H. 2003: NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO Journal 22(15): 3898-3909
Clarkson, R.W.; Heeley, J.L.; Chapman, R.; Aillet, F.; Hay, R.T.; Wyllie, A.; Watson, C.J. 2000: NF-kappaB inhibits apoptosis in murine mammary epithelia. Journal of Biological Chemistry 275(17): 12737-12742
Rippe, R.A.; Schrum, L.W.; Stefanovic, B.; Solís-Herruzo, J.A.; Brenner, D.A. 1999: NF-kappaB inhibits expression of the alpha1(I) collagen gene. Dna and Cell Biology 18(10): 751-761
Brown, H.J.; Song, M.Jung.; Deng, H.; Wu, T-Ting.; Cheng, G.; Sun, R. 2003: NF-kappaB inhibits gammaherpesvirus lytic replication. Journal of Virology 77(15): 8532-8540
Zhang, W.; Kone, B.C. 2002: NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. American Journal of Physiology. Renal Physiology 283(5): F904-F911
Arima, N.; Matsushita, K.; Obata, H.; Ohtsubo, H.; Fujiwara, H.; Arimura, K.; Kukita, T.; Suruga, Y.; Wakamatsu, S.; Hidaka, S.; Tei, C. 1999: NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Experimental Hematology 27(7): 1168-1175
Miyoshi, H.; Rust, C.; Guicciardi, M.E.; Gores, G.J. 2001: NF-kappaB is activated in cholestasis and functions to reduce liver injury. American Journal of Pathology 158(3): 967-975
Narayanan, K.; Balakrishnan, A.; Miyamoto, S. 2000: NF-kappaB is essential for induction of pro-inflammatory cytokine genes by filarial parasitic sheath proteins. Molecular Immunology 37(3-4): 115-123
Méndez-Samperio, P.; Ayala, H.; Vázquez, A. 2003: NF-kappaB is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guérin-activated human T cells. Clinical and Diagnostic Laboratory Immunology 10(3): 376-382
Mejdoubi, N.; Henriques, C.; Bui, E.; Porquet, D. 1999: NF-kappaB is involved in the induction of the rat hepatic alpha1-acid glycoprotein gene by phenobarbital. Biochemical and Biophysical Research Communications 254(1): 93-99
Srahna, M.; Remacle, J.E.; Annamalai, K.; Pype, S.; Huylebroeck, D.; Boogaerts, M.A.; Vandenberghe, P. 2001: NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells. Clinical and Experimental Immunology 125(2): 229-236
Koulich, E.; Nguyen, T.; Johnson, K.; Giardina, C.; D'mello, S. 2001: NF-kappaB is involved in the survival of cerebellar granule neurons: association of Ikappa Bbeta [correction of Ikappabeta] phosphorylation with cell survival. Journal of Neurochemistry 76(4): 1188-1198
Kaku, H.; Horikawa, K.; Obata, Y.; Kato, I.; Okamoto, H.; Sakaguchi, N.; Gerondakis, S.; Takatsu, K. 2002: NF-kappaB is required for CD38-mediated induction of C(gamma)1 germline transcripts in murine B lymphocytes. International Immunology 14(9): 1055-1064
Jo, H.; Zhang, R.; Zhang, H.; Mckinsey, T.A.; Shao, J.; Beauchamp, R.D.; Ballard, D.W.; Liang, P. 2000: NF-kappaB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene 19(7): 841-849
Wang, Z.; Castresana, M.R.; Newman, W.H. 2001: NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration. Febs Letters 508(3): 360-364
Goodkin, M.L.; Ting, A.T.; Blaho, J.A. 2003: NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. Journal of Virology 77(13): 7261-7280
Nitta, T.; Chiba, A.; Yamashita, A.; Rowe, M.; Israël, A.; Reth, M.; Yamamoto, N.; Yamaoka, S. 2003: NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus. Cellular Signalling 15(4): 423-433
Bushdid, P.B.; Chen, C.L.; Brantley, D.M.; Yull, F.; Raghow, R.; Kerr, L.D.; Barnett, J.V. 2001: NF-kappaB mediates FGF signal regulation of msx-1 expression. Developmental Biology 237(1): 107-115
Gao, F.; Bales, K.R.; Dodel, R.C.; Liu, J.; Chen, X.; Hample, H.; Farlow, M.R.; Paul, S.M.; Du, Y. 2002: NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line. Brain Research. Molecular Brain Research 105(1-2): 108-114
Sitcheran, R.; Cogswell, P.C.; Baldwin, A.S. 2003: NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes and Development 17(19): 2368-2373
Li, Y.P.; Reid, M.B. 2000: NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 279(4): R1165-R1170
Miller, S.C.; Haberer, J.; Venkatachalam, U.; Furniss, M.J. 1999: NF-kappaB or AP-1-dependent reporter gene expression is not altered in human U937 cells exposed to power-line frequency magnetic fields. Radiation Research 151(3): 310-318
Xing, L.; Bushnell, T.P.; Carlson, L.; Tai, Z.; Tondravi, M.; Siebenlist, U.; Young, F.; Boyce, B.F. 2002: NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(7): 1200-1210
Pennypacker, K.R.; Kassed, C.A.; Eidizadeh, S.; Saporta, S.; Sanberg, P.R.; Willing, A.E. 2001: NF-kappaB p50 is increased in neurons surviving hippocampal injury. Experimental Neurology 172(2): 307-319
Chen, Y.Q.; Sengchanthalangsy, L.L.; Hackett, A.; Ghosh, G. 2000: NF-kappaB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure 8(4): 419-428
Figueroa, Y.G.; Chan, A.K.; Ibrahim, R.; Tang, Y.; Burow, M.E.; Alam, J.; Scandurro, A.B.; Beckman, B.S. 2002: NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Experimental Hematology 30(12): 1419-1427
Helbig, G.; Christopherson, K.W.; Bhat-Nakshatri, P.; Kumar, S.; Kishimoto, H.; Miller, K.D.; Broxmeyer, H.E.; Nakshatri, H. 2003: NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. Journal of Biological Chemistry 278(24): 21631-21638
Tolnay, M.; Vereshchagina, L.A.; Tsokos, G.C. 2002: NF-kappaB regulates the expression of the human complement receptor 2 gene. Journal of Immunology 169(11): 6236-6243
Rivera-Walsh, I.; Waterfield, M.; Xiao, G.; Fong, A.; Sun, S.C. 2001: NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. Journal of Biological Chemistry 276(44): 40385-40388
Nelson, G.; Wilde, G.J.C.; Spiller, D.G.; Kennedy, S.M.; Ray, D.W.; Sullivan, E.; Unitt, J.F.; White, M.R.H. 2003: NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms. Journal of Cell Science 116(Part 12): 2495-2503
Micheau, O.; Lens, S.; Gaide, O.; Alevizopoulos, K.; Tschopp, J. 2001: NF-kappaB signals induce the expression of c-FLIP. Molecular and Cellular Biology 21(16): 5299-5305
Feng, J.Q.; Xing, L.; Zhang, J-Hong.; Zhao, M.; Horn, D.; Chan, J.; Boyce, B.F.; Harris, S.E.; Mundy, G.R.; Chen, D. 2003: NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. Journal of Biological Chemistry 278(31): 29130-29135
Hatano, E.; Bennett, B.L.; Manning, A.M.; Qian, T.; Lemasters, J.J.; Brenner, D.A. 2001: NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Gastroenterology 120(5): 1251-1262
Chen, F.; Shi, X. 2002: NF-kappaB, a pivotal transcription factor in silica-induced diseases. Molecular and Cellular Biochemistry 234-235(1-2): 169-176
Lim, J.W.; Kim, H.; Kim, K.H. 2001: NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection. Free Radical Biology and Medicine 31(3): 355-366
Welters, I.D.; Fimiani, C.; Bilfinger, T.V.; Stefano, G.B. 2000: NF-kappaB, nitric oxide and opiate signaling. Medical Hypotheses 54(2): 263-268
Garcia, G.E.; Xia, Y.; Chen, S.; Wang, Y.; Ye, R.D.; Harrison, J.K.; Bacon, K.B.; Zerwes, H.G.; Feng, L. 2000: NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. Journal of Leukocyte Biology 67(4): 577-584
Han, M-Kwan.; Kim, J-Suk.; Park, B-Hyun.; Kim, J-Ryul.; Hwang, B-Yun.; Lee, H-Yong.; Song, E-Kyung.; Yoo, W-Hee. 2003: NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. Journal of Leukocyte Biology 73(4): 525-529
Guttridge, D.C.; Mayo, M.W.; Madrid, L.V.; Wang, C.Y.; Baldwin, A.S. 2000: NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289(5488): 2363-2366
Xiao, G.; Harhaj, E.W.; Sun, S.C. 2001: NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Molecular Cell 7(2): 401-409
Basile, J.R.; Eichten, A.; Zacny, V.; Münger, K. 2003: NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Molecular Cancer Research: Mcr 1(4): 262-270
Kitamura, M. 1999: NF-kappaB-mediated self defense of macrophages faced with bacteria. European Journal of Immunology 29(5): 1647-1655
Shou, Y.; Li, N.; Li, L.; Borowitz, J.L.; Isom, G.E. 2002: NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. Journal of Neurochemistry 81(4): 842-852
Lee, H.H.; Dadgostar, H.; Cheng, Q.; Shu, J.; Cheng, G. 1999: NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 96(16): 9136-9141
Xu, J.; Xie, J.; Bao, M.; Li, Z.; Yang, Z. 2003: NF-kappaB/I-kappaB pathway during ischemia reperfusion injury of rat liver. Chinese Medical Journal 116(8): 1146-1149
Feng, Z.; Porter, A.G. 1999: NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells. Journal of Biological Chemistry 274(43): 30341-30344
Lu, Y.; Jamieson, L.; Brasier, A.R.; Fields, A.P. 2001: NF-kappaB/RelA transactivation is required for atypical protein kinase Ciota-mediated cell survival. Oncogene 20(35): 4777-4792, 9 August
Zelazowski, P.; Shen, Y.; Snapper, C.M. 2000: NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner. International Immunology 12(8): 1167-1172
Kurland, J.F.; Kodym, R.; Story, M.D.; Spurgers, K.B.; McDonnell, T.J.; Meyn, R.E. 2001: NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. Journal of Biological Chemistry 276(48): 45380-45386
Kastenbauer, S.; Ziegler-Heitbrock, H.W. 1999: NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infection and Immunity 67(4): 1553-1559
Nakamura, Y.; Grumont, R.J.; Gerondakis, S. 2002: NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression. Molecular and Cellular Biology 22(15): 5563-5574
Beinke, S.; Deka, J.; Lang, V.; Belich, M.P.; Walker, P.A.; Howell, S.; Smerdon, S.J.; Gamblin, S.J.; Ley, S.C. 2003: NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity. Molecular and Cellular Biology 23(14): 4739-4752
Waterfield, M.R.; Zhang, M.; Norman, L.P.; Sun, S.Cong. 2003: NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Molecular Cell 11(3): 685-694
Wang, Y.; Cui, H.; Schroering, A.; Ding, J.L.; Lane, W.S.; Mcgill, G.; Fisher, D.E.; Ding, H.F.i 2002: NF-kappaB2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nature Cell Biology 4(11): 888-893
Viatour, P.; Bentires-Alj, M.; Chariot, A.; Deregowski, V.; De-Leval, L.; Merville, M.P.; Bours, V.[author, Reprint-Author] 2003: NF-kappaB2/p100 induces Bcl-2 expression. Leukemia 17(7): 1349-1356
Perry, A.; Roth, K.A.; Banerjee, R.; Fuller, C.E.; Gutmann, D.H. 2001: NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. American Journal of Pathology 159(1): 57-61
De Luca, A.; Buccino, A.; Gianni, D.; Mangino, M.; Giustini, S.; Richetta, A.; Divona, L.; Calvieri, S.; Mingarelli, R.; Dallapiccola, B. 2003: NF1 gene analysis based on DHPLC. Human Mutation 21(2): 171-172
Rasmussen, S.A.; Friedman, J.M. 2000: NF1 gene and neurofibromatosis 1. American Journal of Epidemiology 151(1): 33-40
Riva, P.; Corrado, L.; Natacci, F.; Castorina, P.; Wu, B.L.; Schneider, G.H.; Clementi, M.; Tenconi, R.; Korf, B.R.; Larizza, L. 2000: NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. American Journal of Human Genetics 66(1): 100-109
Kluwe, L.; Tatagiba, M.; Fünsterer, C.; Mautner, V.-F. 2003: NF1 mutations and clinical spectrum in patients with spinal neurofibromas. Journal of Medical Genetics 40(5): 368-371
Thomson, S.A.M.; Fishbein, L.; Wallace, M.R. 2002: NF1 mutations and molecular testing. Journal of Child Neurology 17(8): 555-61; Discussion 571-2 646-51
Rafty, L.A.; Santiago, F.S.; Khachigian, L.M. 2002: NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter. EMBO Journal 21(3): 334-343
López-Correa, C.; Zucman-Rossi, J.; Brems, H.; Thomas, G.; Legius, E. 2000: NF2 gene deletion in a family with a mild phenotype. Journal of Medical Genetics 37(1): 75-77
Zucman-Rossi, J.; Legoix, P.; Der Sarkissian, H.; Cheret, G.; Sor, F.; Bernardi, A.; Cazes, L.; Giraud, S.; Ollagnon, E.; Lenoir, G.; Thomas, G. 1998: NF2 gene in neurofibromatosis type 2 patients. Human Molecular Genetics 7(13): 2095-2101
Kros, J.; de Greve, K.; van Tilborg, A.; Hop, W.; Pieterman, H.; Avezaat, C.; Lekanne Dit Deprez, R.; Zwarthoff, E. 2001: NF2 status of meningiomas is associated with tumour localization and histology. Journal of Pathology 194(3): 367-372
Szijan, I.; Rochefort, D.; Bruder, C.; Surace, E.; Machiavelli, G.; Dalamon, V.; Cotignola, J.; Ferreiro, V.; Campero, A.; Basso, A.; Dumanski, J.P.; Rouleau, G.A. 2003: NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. Neuromolecular Medicine 3(1): 41-52
Xiao, G.-H.; Chernoff, J.; Testa, J.R. 2003: NF2: the wizardry of merlin. Genes Chromosomes and Cancer 38(4): 389-399
Hülsmann, M.; Nickel, P.; Kassack, M.; Schmalzing, Günther.; Lambrecht, Günter.; Markwardt, F. 2003: NF449, a novel picomolar potency antagonist at human P2X1 receptors. European Journal of Pharmacology 470(1-2): 1-7
Braun, K.; Rettinger, J.; Ganso, M.; Kassack, M.; Hildebrandt, C.; Ullmann, H.; Nickel, P.; Schmalzing, G.; Lambrecht, G. 2001: NF449: A subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 364(3): 285-290
Tomida, T.; Hirose, K.; Takizawa, A.; Shibasaki, F.; Iino, M. 2003: NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation. EMBO Journal 22(15): 3825-3832
Lawrence, M.C.; Bhatt, H.S.; Easom, R.A. 2002: NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51(3): 691-698
Pu, W.T.; Ma, Q.; Izumo, S. 2003: NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circulation Research 92(7): 725-731
Hooijberg, E.; Bakker, A.Q.; Ruizendaal, J.J.; Spits, H. 2000: NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells. Blood 96(2): 459-466
Monticelli, S.; Rao, A. 2002: NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. European Journal of Immunology 32(10): 2971-2978
Cron, R.Q.; Bartz, S.R.; Clausell, A.; Bort, S.J.; Klebanoff, S.J.; Lewis, D.B. 2000: NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clinical Immunology 94(3): 179-191
Jones, E.A.; Sun, D.; Kobierski, L.; Symes, A.J. 2003: NFAT4 is expressed in primary astrocytes and activated by glutamate. Journal of Neuroscience Research 72(2): 191-197
Stevenson, A.S.; Gomez, M.F.; Hill-Eubanks, D.C.; Nelson, M.T. 2001: NFAT4 movement in native smooth muscle. a role for differential Ca(2+) signaling. Journal of Biological Chemistry 276(18): 15018-15024
Horsley, V.; Pavlath, G.K. 2002: NFAT: Ubiquitous regulator of cell differentiation and adaptation. Journal of Cell Biology 156(5): 771-774
Caetano, M.S.; Vieira-de-Abreu, A.; Teixeira, L.K.; Werneck, M.B.F.; Barcinski, M.A.; Viola, Jão.P.B. 2002: NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB Journal 16(14): 1940-1942